{
  "entity_id": "O-000885",
  "folder": "Australian-Nuclear-Science-and-Technology-Organisation",
  "name": "Australian Nuclear Science and Technology Organisation",
  "type": "Corporate Commonwealth Entity",
  "jurisdiction": "Commonwealth",
  "portfolio": "Industry, Science and Resources",
  "website": "http://www.ansto.gov.au/",
  "data_status": "rich",
  "completeness": {
    "has_strategy_brief": true,
    "has_strategy_structured": true,
    "has_vision": true,
    "has_kpi_targets": true,
    "has_kpi_results": true,
    "has_strategy_overview": true,
    "has_legislation_text": true,
    "has_legislation_structured": true,
    "has_global_initiatives_text": true,
    "has_ideas": true,
    "has_artifacts": true,
    "n_ideas": 8,
    "n_legislation": 6,
    "n_artifacts": 10,
    "n_kpi_targets": 2,
    "n_kpi_results": 2,
    "n_outcomes": 2,
    "verified_own_data": true
  },
  "strategy_profile": {
    "status": "published",
    "confidence": "high",
    "summary": "ANSTO’s purpose is derived from section 5 of the Australian Nuclear Science and Technology Organisation Act 1987 (Cth) (the ANSTO Act), which directs the core functions we undertake for the benefit of Australia, to:\n. Conduct research and development in relation to nuclear science, engineering and technology;\n. Produce and use radioisotopes, isotopic techniques and nuclear radiation for medicine, science, industry, commerce and agriculture;\n. Encourage and facilitate the application and use of results gained from research and development;\n. Manage radioactive materials and waste arising from various prescribed activities;\n. Provide goods and services related to core activities, such as in connection with the production and use of radioisotopes;\n. Provide advice to government and liaise with other countries on behalf of Australia in nuclear-related matters;\n. Make available to other persons – whether or not on a commercial basis – the knowledge, expertise, equipment, facilities, resources and property of the organisation for the purposes of scientific research, innovation and training;\n. Publish scientific and technical reports, periodicals and papers, and provide public information and advice; and\n. Facilitate education and training in nuclear science and technology, including through granting scientific research studentships and fellowships, in cooperation with universities, professional bodies and other education and research institutions.",
    "official_site_url": "http://www.ansto.gov.au/",
    "source_documents": [
      {
        "type": "corporate_plan",
        "title": "View 2024-28 Corporate Plan",
        "url": "https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/337594f0-dcaf-4f17-b733-b131b6b60bf3/2024-25%20Australian%20Nuclear%20Science%20and%20Technology%20Organisation%20Corporate%20Plan.pdf",
        "period": "2024-25",
        "confidence": "high"
      },
      {
        "type": "corporate_plan",
        "title": "View 2023-27 Corporate Plan",
        "url": "https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/29b98a52-490e-47e4-99a5-aef2ceb2fc8a/2023-24_australian_nuclear_science_and_technology_organisation_corporate_plan.pdf",
        "period": "2023-24",
        "confidence": "high"
      },
      {
        "type": "corporate_plan",
        "title": "View 2022-26 Corporate Plan",
        "url": "https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/77ebc9ab-c43d-4751-9e26-49a33639d1b5/2022-23_australian_nuclear_science_and_technology_organisation_corporate_plan.pdf",
        "period": "2022-23",
        "confidence": "high"
      },
      {
        "type": "corporate_plan",
        "title": "View 2021-22 Corporate Plan",
        "url": "https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/2e76500f-0714-43d1-9355-a720584b9972/2021-22_corporate_plan_australian_nuclear_science_and_technology_organisation.pdf",
        "period": "2021-22",
        "confidence": "high"
      },
      {
        "type": "corporate_plan",
        "title": "View 2020-21 Corporate Plan",
        "url": "https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/c9be6c79-f727-452b-adc4-2533f6c9473e/ansto_corporate_plan_2020-2021.pdf",
        "period": "2020-21",
        "confidence": "high"
      }
    ],
    "purpose": {
      "text": "ANSTO’s purpose is derived from section 5 of the Australian Nuclear Science and Technology Organisation Act 1987 (Cth) (the ANSTO Act), which directs the core functions we undertake for the benefit of Australia, to:\n. Conduct research and development in relation to nuclear science, engineering and technology;\n. Produce and use radioisotopes, isotopic techniques and nuclear radiation for medicine, science, industry, commerce and agriculture;\n. Encourage and facilitate the application and use of results gained from research and development;\n. Manage radioactive materials and waste arising from various prescribed activities;\n. Provide goods and services related to core activities, such as in connection with the production and use of radioisotopes;\n. Provide advice to government and liaise with other countries on behalf of Australia in nuclear-related matters;\n. Make available to other persons – whether or not on a commercial basis – the knowledge, expertise, equipment, facilities, resources and property of the organisation for the purposes of scientific research, innovation and training;\n. Publish scientific and technical reports, periodicals and papers, and provide public information and advice; and\n. Facilitate education and training in nuclear science and technology, including through granting scientific research studentships and fellowships, in cooperation with universities, professional bodies and other education and research institutions.",
      "source_url": "https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/337594f0-dcaf-4f17-b733-b131b6b60bf3/2024-25%20Australian%20Nuclear%20Science%20and%20Technology%20Organisation%20Corporate%20Plan.pdf",
      "source_page": 11,
      "source_deep_url": "https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/337594f0-dcaf-4f17-b733-b131b6b60bf3/2024-25%20Australian%20Nuclear%20Science%20and%20Technology%20Organisation%20Corporate%20Plan.pdf#page=11"
    },
    "vision": {
      "text": "Nuclear science and technology for the benefit of all Australians",
      "source_url": "https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/337594f0-dcaf-4f17-b733-b131b6b60bf3/2024-25%20Australian%20Nuclear%20Science%20and%20Technology%20Organisation%20Corporate%20Plan.pdf",
      "source_page": 2,
      "source_deep_url": "https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/337594f0-dcaf-4f17-b733-b131b6b60bf3/2024-25%20Australian%20Nuclear%20Science%20and%20Technology%20Organisation%20Corporate%20Plan.pdf#page=2"
    },
    "strategic_priorities": [
      {
        "title": "Deliver on Australia’s priorities for the benefit of people, industry and the environment through nuclear excellence in ",
        "description": "Deliver on Australia’s priorities for the benefit of people, industry and the environment through nuclear excellence in research and the use of national infrastructure",
        "source_url": "https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/337594f0-dcaf-4f17-b733-b131b6b60bf3/2024-25%20Australian%20Nuclear%20Science%20and%20Technology%20Organisation%20Corporate%20Plan.pdf",
        "source_page": 18,
        "source_deep_url": "https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/337594f0-dcaf-4f17-b733-b131b6b60bf3/2024-25%20Australian%20Nuclear%20Science%20and%20Technology%20Organisation%20Corporate%20Plan.pdf#page=18"
      },
      {
        "title": "Improve the health of Australia by supporting access to current and future nuclear technologies for diagnostic, therapeu",
        "description": "Improve the health of Australia by supporting access to current and future nuclear technologies for diagnostic, therapeutic and innovative treatments for current and emerging diseases",
        "source_url": "https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/337594f0-dcaf-4f17-b733-b131b6b60bf3/2024-25%20Australian%20Nuclear%20Science%20and%20Technology%20Organisation%20Corporate%20Plan.pdf",
        "source_page": 30,
        "source_deep_url": "https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/337594f0-dcaf-4f17-b733-b131b6b60bf3/2024-25%20Australian%20Nuclear%20Science%20and%20Technology%20Organisation%20Corporate%20Plan.pdf#page=30"
      },
      {
        "title": "Australia’s source of nuclear expertise, advice and services to governments, academia, industry, and community",
        "description": "Australia’s source of nuclear expertise, advice and services to governments, academia, industry, and community",
        "source_url": "https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/337594f0-dcaf-4f17-b733-b131b6b60bf3/2024-25%20Australian%20Nuclear%20Science%20and%20Technology%20Organisation%20Corporate%20Plan.pdf",
        "source_page": 32,
        "source_deep_url": "https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/337594f0-dcaf-4f17-b733-b131b6b60bf3/2024-25%20Australian%20Nuclear%20Science%20and%20Technology%20Organisation%20Corporate%20Plan.pdf#page=32"
      },
      {
        "title": "Lead the development of a nuclear-capable workforce aligned with government policy objectives",
        "description": "Lead the development of a nuclear-capable workforce aligned with government policy objectives",
        "source_url": "https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/337594f0-dcaf-4f17-b733-b131b6b60bf3/2024-25%20Australian%20Nuclear%20Science%20and%20Technology%20Organisation%20Corporate%20Plan.pdf",
        "source_page": 36,
        "source_deep_url": "https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/337594f0-dcaf-4f17-b733-b131b6b60bf3/2024-25%20Australian%20Nuclear%20Science%20and%20Technology%20Organisation%20Corporate%20Plan.pdf#page=36"
      }
    ],
    "values": [
      {
        "name": "Curiosity",
        "description": "",
        "source_url": "https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/337594f0-dcaf-4f17-b733-b131b6b60bf3/2024-25%20Australian%20Nuclear%20Science%20and%20Technology%20Organisation%20Corporate%20Plan.pdf",
        "source_page": null
      },
      {
        "name": "Leadership",
        "description": "",
        "source_url": "https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/337594f0-dcaf-4f17-b733-b131b6b60bf3/2024-25%20Australian%20Nuclear%20Science%20and%20Technology%20Organisation%20Corporate%20Plan.pdf",
        "source_page": null
      },
      {
        "name": "Excellence",
        "description": "",
        "source_url": "https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/337594f0-dcaf-4f17-b733-b131b6b60bf3/2024-25%20Australian%20Nuclear%20Science%20and%20Technology%20Organisation%20Corporate%20Plan.pdf",
        "source_page": null
      },
      {
        "name": "Working together",
        "description": "",
        "source_url": "https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/337594f0-dcaf-4f17-b733-b131b6b60bf3/2024-25%20Australian%20Nuclear%20Science%20and%20Technology%20Organisation%20Corporate%20Plan.pdf",
        "source_page": null
      },
      {
        "name": "Trust + Respect",
        "description": "",
        "source_url": "https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/337594f0-dcaf-4f17-b733-b131b6b60bf3/2024-25%20Australian%20Nuclear%20Science%20and%20Technology%20Organisation%20Corporate%20Plan.pdf",
        "source_page": null
      },
      {
        "name": "Safe",
        "description": "",
        "source_url": "https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/337594f0-dcaf-4f17-b733-b131b6b60bf3/2024-25%20Australian%20Nuclear%20Science%20and%20Technology%20Organisation%20Corporate%20Plan.pdf",
        "source_page": null
      },
      {
        "name": "Secure",
        "description": "",
        "source_url": "https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/337594f0-dcaf-4f17-b733-b131b6b60bf3/2024-25%20Australian%20Nuclear%20Science%20and%20Technology%20Organisation%20Corporate%20Plan.pdf",
        "source_page": null
      },
      {
        "name": "Sustainable",
        "description": "",
        "source_url": "https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/337594f0-dcaf-4f17-b733-b131b6b60bf3/2024-25%20Australian%20Nuclear%20Science%20and%20Technology%20Organisation%20Corporate%20Plan.pdf",
        "source_page": null
      }
    ],
    "outcomes": [
      {
        "name": "Outcome 1: Deliver on Australia’s priorities for the benefit of people, industry and the environment through nuclear excellence in research and the use of national infrastructure",
        "description": "Operate world-class research infrastructure and leverage capabilities to deliver outcomes for Australia",
        "activities": [
          "OPAL multi-purpose nuclear reactor upgrades",
          "ANSTO’s Australian Centre for Neutron Scattering (ACNS) upgrades"
        ],
        "source_url": "https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/337594f0-dcaf-4f17-b733-b131b6b60bf3/2024-25%20Australian%20Nuclear%20Science%20and%20Technology%20Organisation%20Corporate%20Plan.pdf",
        "source_page": 19,
        "source_deep_url": "https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/337594f0-dcaf-4f17-b733-b131b6b60bf3/2024-25%20Australian%20Nuclear%20Science%20and%20Technology%20Organisation%20Corporate%20Plan.pdf#page=19"
      },
      {
        "name": "Outcome 2: Improve the health of Australia by supporting access to current and future nuclear technologies for diagnostic, therapeutic and innovative treatments for current and emerging diseases",
        "description": "ANSTO’s Australian Synchrotron, ANSTO’s research facility located at our campus in Victoria, utilises accelerator technology to produce powerful beams of light, up to a million times brighter than the light from the sun.",
        "activities": [
          "Project BRIGHT"
        ],
        "source_url": "https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/337594f0-dcaf-4f17-b733-b131b6b60bf3/2024-25%20Australian%20Nuclear%20Science%20and%20Technology%20Organisation%20Corporate%20Plan.pdf",
        "source_page": 45,
        "source_deep_url": "https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/337594f0-dcaf-4f17-b733-b131b6b60bf3/2024-25%20Australian%20Nuclear%20Science%20and%20Technology%20Organisation%20Corporate%20Plan.pdf#page=45"
      }
    ],
    "performance_measures": [
      {
        "code": "CCE01",
        "measure": "Year on year decrease in class 2 & 3 incidents",
        "target": "Zero class 1 incidents",
        "latest_result": "Partially achieved",
        "status": "Partially achieved",
        "target_source_url": "https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/337594f0-dcaf-4f17-b733-b131b6b60bf3/2024-25%20Australian%20Nuclear%20Science%20and%20Technology%20Organisation%20Corporate%20Plan.pdf",
        "target_source_page": 14,
        "result_source_url": "",
        "result_source_page": 14
      },
      {
        "code": "CCE02",
        "measure": "Improvement in site-wide safety",
        "target": "Improvement in safety culture to actual incidents recorded",
        "latest_result": "Improvement in safety culture",
        "status": "Partially achieved",
        "target_source_url": "https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/337594f0-dcaf-4f17-b733-b131b6b60bf3/2024-25%20Australian%20Nuclear%20Science%20and%20Technology%20Organisation%20Corporate%20Plan.pdf",
        "target_source_page": 14,
        "result_source_url": "",
        "result_source_page": 14
      }
    ],
    "document_alignment_terms": {
      "must_support": [
        "ANSTO’s purpose is derived from section 5 of the Australian Nuclear Science and Technology Organisation Act 1987 (Cth) (the ANSTO Act), which directs the core functions we undertak",
        "Nuclear science and technology for the benefit of all Australians",
        "Deliver on Australia’s priorities for the benefit of people, industry and the environment through nuclear excellence in research and the use of national infrastructure",
        "Improve the health of Australia by supporting access to current and future nuclear technologies for diagnostic, therapeutic and innovative treatments for current and emerging diseases",
        "Australia’s source of nuclear expertise, advice and services to governments, academia, industry, and community",
        "Lead the development of a nuclear-capable workforce aligned with government policy objectives"
      ],
      "watch_terms": [
        "Year on year decrease in class 2 & 3 incidents",
        "Improvement in site-wide safety"
      ],
      "avoid_claiming_without_evidence": []
    },
    "review_note": ""
  },
  "strategy_brief_md": "# Australian Nuclear Science and Technology Organisation — Strategy Brief\n\n**Reporting period**: 2024-25\n**Corporate plan in force**: 2025-26\n**Corporate Plan**: [2025-26](https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/337594f0-dcaf-4f17-b733-b131b6b60bf3/2024-25%20Australian%20Nuclear%20Science%20and%20Technology%20Organisation%20Corporate%20Plan.pdf)\n\n## Vision\n\n> Nuclear science and technology for the benefit of all Australians [[CP p.2](https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/337594f0-dcaf-4f17-b733-b131b6b60bf3/2024-25%20Australian%20Nuclear%20Science%20and%20Technology%20Organisation%20Corporate%20Plan.pdf#page=2)(https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/337594f0-dcaf-4f17-b733-b131b6b60bf3/2024-25%20Australian%20Nuclear%20Science%20and%20Technology%20Organisation%20Corporate%20Plan.pdf#page=2)]\n\n## Our purpose / purposes\n\n> ANSTO’s purpose is derived from section 5 of the Australian Nuclear Science and Technology Organisation Act 1987 (Cth) (the ANSTO Act), which directs the core functions we undertake for the benefit of Australia, to:\n. Conduct research and development in relation to nuclear science, engineering and technology;\n. Produce and use radioisotopes, isotopic techniques and nuclear radiation for medicine, science, industry, commerce and agriculture;\n. Encourage and facilitate the application and use of results gained from research and development;\n. Manage radioactive materials and waste arising from various prescribed activities;\n. Provide goods and services related to core activities, such as in connection with the production and use of radioisotopes;\n. Provide advice to government and liaise with other countries on behalf of Australia in nuclear-related matters;\n. Make available to other persons – whether or not on a commercial basis – the knowledge, expertise, equipment, facilities, resources and property of the organisation for the purposes of scientific research, innovation and training;\n. Publish scientific and technical reports, periodicals and papers, and provide public information and advice; and\n. Facilitate education and training in nuclear science and technology, including through granting scientific research studentships and fellowships, in cooperation with universities, professional bodies and other education and research institutions. [[CP p.11](https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/337594f0-dcaf-4f17-b733-b131b6b60bf3/2024-25%20Australian%20Nuclear%20Science%20and%20Technology%20Organisation%20Corporate%20Plan.pdf#page=11)(https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/337594f0-dcaf-4f17-b733-b131b6b60bf3/2024-25%20Australian%20Nuclear%20Science%20and%20Technology%20Organisation%20Corporate%20Plan.pdf#page=11)]\n\n## How we deliver\n\n> ANSTO operates Australia’s only nuclear reactor, and we address some of the most challenging issues facing Australia in the fields of health, environment, advanced manufacturing, defence, and national security. [[CP p.8](https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/337594f0-dcaf-4f17-b733-b131b6b60bf3/2024-25%20Australian%20Nuclear%20Science%20and%20Technology%20Organisation%20Corporate%20Plan.pdf#page=8)(https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/337594f0-dcaf-4f17-b733-b131b6b60bf3/2024-25%20Australian%20Nuclear%20Science%20and%20Technology%20Organisation%20Corporate%20Plan.pdf#page=8)]\n\n## Government priorities for this department\n\n- Deliver on Australia’s priorities for the benefit of people, industry and the environment through nuclear excellence in research and the use of national infrastructure [[CP p.18](https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/337594f0-dcaf-4f17-b733-b131b6b60bf3/2024-25%20Australian%20Nuclear%20Science%20and%20Technology%20Organisation%20Corporate%20Plan.pdf#page=18)(https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/337594f0-dcaf-4f17-b733-b131b6b60bf3/2024-25%20Australian%20Nuclear%20Science%20and%20Technology%20Organisation%20Corporate%20Plan.pdf#page=18)]\n- Improve the health of Australia by supporting access to current and future nuclear technologies for diagnostic, therapeutic and innovative treatments for current and emerging diseases [[CP p.30](https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/337594f0-dcaf-4f17-b733-b131b6b60bf3/2024-25%20Australian%20Nuclear%20Science%20and%20Technology%20Organisation%20Corporate%20Plan.pdf#page=30)(https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/337594f0-dcaf-4f17-b733-b131b6b60bf3/2024-25%20Australian%20Nuclear%20Science%20and%20Technology%20Organisation%20Corporate%20Plan.pdf#page=30)]\n- Australia’s source of nuclear expertise, advice and services to governments, academia, industry, and community [[CP p.32](https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/337594f0-dcaf-4f17-b733-b131b6b60bf3/2024-25%20Australian%20Nuclear%20Science%20and%20Technology%20Organisation%20Corporate%20Plan.pdf#page=32)(https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/337594f0-dcaf-4f17-b733-b131b6b60bf3/2024-25%20Australian%20Nuclear%20Science%20and%20Technology%20Organisation%20Corporate%20Plan.pdf#page=32)]\n- Lead the development of a nuclear-capable workforce aligned with government policy objectives [[CP p.36](https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/337594f0-dcaf-4f17-b733-b131b6b60bf3/2024-25%20Australian%20Nuclear%20Science%20and%20Technology%20Organisation%20Corporate%20Plan.pdf#page=36)(https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/337594f0-dcaf-4f17-b733-b131b6b60bf3/2024-25%20Australian%20Nuclear%20Science%20and%20Technology%20Organisation%20Corporate%20Plan.pdf#page=36)]\n\n## Outcomes\n\n### Outcome 1: Deliver on Australia’s priorities for the benefit of people, industry and the environment through nuclear excellence in research and the use of national infrastructure\nOperate world-class research infrastructure and leverage capabilities to deliver outcomes for Australia [[CP p.19](https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/337594f0-dcaf-4f17-b733-b131b6b60bf3/2024-25%20Australian%20Nuclear%20Science%20and%20Technology%20Organisation%20Corporate%20Plan.pdf#page=19)(https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/337594f0-dcaf-4f17-b733-b131b6b60bf3/2024-25%20Australian%20Nuclear%20Science%20and%20Technology%20Organisation%20Corporate%20Plan.pdf#page=19)]\n\n**Key activities:**\n- OPAL multi-purpose nuclear reactor upgrades\n- ANSTO’s Australian Centre for Neutron Scattering (ACNS) upgrades\n\n### Outcome 2: Improve the health of Australia by supporting access to current and future nuclear technologies for diagnostic, therapeutic and innovative treatments for current and emerging diseases\nANSTO’s Australian Synchrotron, ANSTO’s research facility located at our campus in Victoria, utilises accelerator technology to produce powerful beams of light, up to a million times brighter than the light from the sun. [[CP p.45](https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/337594f0-dcaf-4f17-b733-b131b6b60bf3/2024-25%20Australian%20Nuclear%20Science%20and%20Technology%20Organisation%20Corporate%20Plan.pdf#page=45)(https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/337594f0-dcaf-4f17-b733-b131b6b60bf3/2024-25%20Australian%20Nuclear%20Science%20and%20Technology%20Organisation%20Corporate%20Plan.pdf#page=45)]\n\n**Key activities:**\n- Project BRIGHT\n\n## Values and principles\n\n_ANSTO’s values_\n\n- Curiosity\n- Leadership\n- Excellence\n- Working together\n- Trust + Respect\n- Safe\n- Secure\n- Sustainable\n\n## What they will measure themselves on this year (targets from 2025-26 corporate plan)\n\n| Code | Measure | Target | Source |\n|---|---|---|---|\n| CCE01 | Year on year decrease in class 2 & 3 incidents | Zero class 1 incidents | [CP p.14](https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/337594f0-dcaf-4f17-b733-b131b6b60bf3/2024-25%20Australian%20Nuclear%20Science%20and%20Technology%20Organisation%20Corporate%20Plan.pdf#page=14)(https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/337594f0-dcaf-4f17-b733-b131b6b60bf3/2024-25%20Australian%20Nuclear%20Science%20and%20Technology%20Organisation%20Corporate%20Plan.pdf#page=14) |\n| CCE02 | Improvement in site-wide safety | Improvement in safety culture to actual incidents recorded | [CP p.14](https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/337594f0-dcaf-4f17-b733-b131b6b60bf3/2024-25%20Australian%20Nuclear%20Science%20and%20Technology%20Organisation%20Corporate%20Plan.pdf#page=14)(https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/337594f0-dcaf-4f17-b733-b131b6b60bf3/2024-25%20Australian%20Nuclear%20Science%20and%20Technology%20Organisation%20Corporate%20Plan.pdf#page=14) |\n\n## How they performed last year (results from 2024-25 annual report)\n\n| Code | Measure | Result | Status | Source |\n|---|---|---|---|---|\n| CCE01 | Year on year decrease in class 2 & 3 incidents | Partially achieved | Partially achieved | AR p.14 |\n| CCE02 | Improvement in site-wide safety | Improvement in safety culture | Partially achieved | AR p.14 |",
  "strategy_overview_evidence_md": null,
  "internal_strategy_evidence_md": "# Australian Nuclear Science and Technology Organisation - Strategy, Performance, and Operating Profile\n\n**Generated at**: 2026-05-09T21:56:04.597826+00:00\n**Entity ID**: O-000885\n**Entity type**: Corporate Commonwealth Entity\n**Jurisdiction**: Commonwealth\n**Portfolio**: Industry, Science and Resources\n**Website**: http://www.ansto.gov.au/\n\n> Draft generated from scraped source material. Treat this as an evidence pack for editorial review, not a final judgement.\n\n## Source Coverage\n\n| Source type | Count |\n|---|---:|\n| corporate-plans | 5 |\n| global-intelligence | 3 |\n| other-pdfs | 5 |\n| pages | 18 |\n\n## Executive Readout\n\n### Purpose\n\n- [Page 3]\nANSTO vision Contents\n1 Introduction 5\n1.1 A message from the Chair of the Board 5\n1.2 A message from the Chief Executive Officer 6\n2 Our organisation 8\n2.1 Our mission 8\n2.2 What we do 8\n2.3 Our capabilities 9\n2.4 Our people 10\n2.5 Our purpose 11\n2.6 Our values 12\n2.7 Our commitment to safety and community 13\n2.8 Our strategy in summary 16\n3 Our strategy and our priority activities 18\n3.1 STRATEGIC OBJECTIVE 1 –\nDeliver on Australia’s priorities for the benefit of people, industry and the environment through\nnuclear excellence in research and the use of national infrastructure 18\n3.2 STRATEGIC OBJECTIVE 2 –\nImprove the health of Australia by supporting access to current and future nuclear technologies\nfor diagnostic, therapeutic and innovative treatments for current and emerging diseases 30\n3.3 STRATEGIC OBJECTIVE 3 –\n  Source: `corporate-plans/2024.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/337594f0-dcaf-4f17-b733-b131b6b60bf3/2024-25%20Australian%20Nuclear%20Science%20and%20Technology%20Organisation%20Corporate%20Plan.pdf)`\n- [Page 3]\nContents\nIntroduction – A message from the Chair of the Board 4\nIntroduction – A message from the Chief Executive Officer 6\nVision 8\nValues 8\nWhat we do 8\nANSTO’s purpose 11\nANSTO’s operating environment 14\nInternational cooperation 18\nANSTO’s planning and performance process 20\nStrategic objectives 22\nMajor projects 46\nANSTO’s core capabilities 60\nGovernance and oversight of risk management 64\nANSTO Corporate Plan 2020 - 2021 3\n  Source: `corporate-plans/2020-21.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/c9be6c79-f727-452b-adc4-2533f6c9473e/ansto_corporate_plan_2020-2021.pdf)`\n- [Page 2]\nContents\n1 Introduction 5\n1.1 A message from the Chair of the Board 5\n1.2 A message from the Chief Executive Officer 6\n1.3 Vision 8\n1.4 What we do 8\n2 Our purpose and strategy 10\n2.1 Purpose 10\n2.2 Our strategy 11\n2.3 Our values 12\n2.4 Our organisation and people 14\n2.5 Portfolio Budget Statements, Corporate Plan and Annual Report 17\n3 Our operating environment 18\n3.1 National factors 18\n3.2 Global factors 22\n3.3 Cooperation and collaboration 24\n4 Strategy and key activities 26\n4.1 STRATEGIC IMPERATIVE 1 - Research and research infrastructure\nTo conduct research and enable external use of our research capability and infrastructure for the national benefit 26\n4.2 STRATEGIC IMPERATIVE 2 - Commercial products and services\nTo provide nuclear medicines and commercial services for the benefit of Australia and the world 36\n4.3 STRATEGIC IMPERATIVE 3 - Expert and trusted advisor\n  Source: `corporate-plans/2021-22.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/2e76500f-0714-43d1-9355-a720584b9972/2021-22_corporate_plan_australian_nuclear_science_and_technology_organisation.pdf)`\n- Expert and trusted advisor\ninfrastructure services\nEnabling Focus Key\nobjectives areas* activities*\nTo conduct research and enable external To provide nuclear medicines and To be an expert and trusted advisor to\nuse of our research capability and commercial services for the benefit of Government, industry, international\ninfrastructure for the national benefit Australia and the world partners and the Australian public\n* Outlined in Section 4 of the 2021–2022 Corporate Plan\nDeliver and translate research that has Ensure the reliable and sustainable supply Deliver expert advice to Local, State,\nscientific and industry impact, with a focus of nuclear medicines, products and services and Federal Governments and related\n2.1 Purpose on health, the environment and the nuclear stakeholders in support of organisational\nfuel cycle and national interests\n  Source: `corporate-plans/2021-22.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/2e76500f-0714-43d1-9355-a720584b9972/2021-22_corporate_plan_australian_nuclear_science_and_technology_organisation.pdf)`\n\n### Role and Functions\n\n- [Page 2]\nContents\n1 Introduction 5\n1.1 A message from the Chair of the Board 5\n1.2 A message from the Chief Executive Officer 6\n1.3 Vision 8\n1.4 What we do 8\n2 Our purpose and strategy 10\n2.1 Purpose 10\n2.2 Our strategy 11\n2.3 Our values 12\n2.4 Our organisation and people 14\n2.5 Portfolio Budget Statements, Corporate Plan and Annual Report 17\n3 Our operating environment 18\n3.1 National factors 18\n3.2 Global factors 22\n3.3 Cooperation and collaboration 24\n4 Strategy and key activities 26\n4.1 STRATEGIC IMPERATIVE 1 - Research and research infrastructure\nTo conduct research and enable external use of our research capability and infrastructure for the national benefit 26\n4.2 STRATEGIC IMPERATIVE 2 - Commercial products and services\nTo provide nuclear medicines and commercial services for the benefit of Australia and the world 36\n4.3 STRATEGIC IMPERATIVE 3 - Expert and trusted advisor\n  Source: `corporate-plans/2021-22.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/2e76500f-0714-43d1-9355-a720584b9972/2021-22_corporate_plan_australian_nuclear_science_and_technology_organisation.pdf)`\n- [Page 2]\nANSTO vision Contents\n1 Introduction 5\n1.1 A message from the Chair of the Board 5\nNuclear science and\n1.2 A message from the Chief Executive Officer 6\n2 Our organisation 8\n2.1 What we do 8\ntechnology for the\n2.2 Purpose 9\n2.3 Our people 10\nbenefit of all Australians 2.4 Our values 11\n2.5 Safety culture 12\n2.6 Our traditional owners 13\n2.7 Our strategy in summary 14\n3 Our strategy and our priority activities 16\n3.1 STRATEGIC OBJECTIVE 1 –\nDeliver on Australia’s priorities for the benefit of people, industry and the environment through\nnuclear excellence in research and the use of national infrastructure 16\n3.2 STRATEGIC OBJECTIVE 2 –\nImprove the health of Australia by supporting access to current and future nuclear technologies\nfor diagnostic, therapeutic and innovative treatments for current and emerging diseases 26\n3.3 STRATEGIC OBJECTIVE 3 –\n  Source: `corporate-plans/2022.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/77ebc9ab-c43d-4751-9e26-49a33639d1b5/2022-23_australian_nuclear_science_and_technology_organisation_corporate_plan.pdf)`\n- [Page 3]\nANSTO vision Contents\n1 Introduction 5\n1.1 A message from the Chair of the Board 5\n1.2 A message from the Chief Executive Officer 6\n2 Our organisation 8\n2.1 Our mission 8\n2.2 What we do 8\n2.3 Our capabilities 9\n2.4 Our people 10\n2.5 Our purpose 11\n2.6 Our values 12\n2.7 Our commitment to safety and community 13\n2.8 Our strategy in summary 16\n3 Our strategy and our priority activities 18\n3.1 STRATEGIC OBJECTIVE 1 –\nDeliver on Australia’s priorities for the benefit of people, industry and the environment through\nnuclear excellence in research and the use of national infrastructure 18\n3.2 STRATEGIC OBJECTIVE 2 –\nImprove the health of Australia by supporting access to current and future nuclear technologies\nfor diagnostic, therapeutic and innovative treatments for current and emerging diseases 30\n3.3 STRATEGIC OBJECTIVE 3 –\n  Source: `corporate-plans/2024.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/337594f0-dcaf-4f17-b733-b131b6b60bf3/2024-25%20Australian%20Nuclear%20Science%20and%20Technology%20Organisation%20Corporate%20Plan.pdf)`\n- ANSTO produces nuclear medicines to improve the health of the Australian community and plays a vital role as an adviser to the leaders and entrepreneurs engage with science, technology\nAustralian Government, industry and education sectors, as well as the broader community on nuclear technology. and industry. nandin has over 30 start-ups that are connected\nto ANSTO’s leading research talent, including industry-focused\nANSTO activities span manufacturing, research and advisory functions linked to our mandate including: graduates, seeking to develop the next generation of thinking\nNuclear medicine production and Advanced manufacturing and 2.2 Purpose\nhuman health research: support for the resources sector:\n  Source: `corporate-plans/2022.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/77ebc9ab-c43d-4751-9e26-49a33639d1b5/2022-23_australian_nuclear_science_and_technology_organisation_corporate_plan.pdf)`\n- [Page 15]\n3.3 STRATEGIC OBJECTIVE 3 –\nAustralia’s source of nuclear expertise, advice and services\nto governments, academia, industry and community\nDeliver expert advice to local, state and federal governments, and other Participate in global and regional nuclear discussions and forums to ensure that\n3.3.1 3.3.2\nstakeholders to support the national interest Australia remains a leader in the application of nuclear science and technology\nAs a Corporate Commonwealth Entity within the Industry, Science and Resources Portfolio, ANSTO plays a vital role in providing expert ANSTO, as Australia’s national nuclear research organisation and the centre of Australian nuclear expertise, has obligations to act as a\nadvice to the Australian Government on all nuclear science and technology related matters.\n  Source: `corporate-plans/2022.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/77ebc9ab-c43d-4751-9e26-49a33639d1b5/2022-23_australian_nuclear_science_and_technology_organisation_corporate_plan.pdf)`\n- [Page 3]\nContents\nIntroduction – A message from the Chair of the Board 4\nIntroduction – A message from the Chief Executive Officer 6\nVision 8\nValues 8\nWhat we do 8\nANSTO’s purpose 11\nANSTO’s operating environment 14\nInternational cooperation 18\nANSTO’s planning and performance process 20\nStrategic objectives 22\nMajor projects 46\nANSTO’s core capabilities 60\nGovernance and oversight of risk management 64\nANSTO Corporate Plan 2020 - 2021 3\n  Source: `corporate-plans/2020-21.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/c9be6c79-f727-452b-adc4-2533f6c9473e/ansto_corporate_plan_2020-2021.pdf)`\n\n### Strategic Priorities\n\n- [Page 2]\nANSTO vision Contents\n1 Introduction 5\n1.1 A message from the Chair of the Board 5\nNuclear science and\n1.2 A message from the Chief Executive Officer 6\n2 Our organisation 8\n2.1 What we do 8\ntechnology for the\n2.2 Purpose 9\n2.3 Our people 10\nbenefit of all Australians 2.4 Our values 11\n2.5 Safety culture 12\n2.6 Our traditional owners 13\n2.7 Our strategy in summary 14\n3 Our strategy and our priority activities 16\n3.1 STRATEGIC OBJECTIVE 1 –\nDeliver on Australia’s priorities for the benefit of people, industry and the environment through\nnuclear excellence in research and the use of national infrastructure 16\n3.2 STRATEGIC OBJECTIVE 2 –\nImprove the health of Australia by supporting access to current and future nuclear technologies\nfor diagnostic, therapeutic and innovative treatments for current and emerging diseases 26\n3.3 STRATEGIC OBJECTIVE 3 –\n  Source: `corporate-plans/2022.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/77ebc9ab-c43d-4751-9e26-49a33639d1b5/2022-23_australian_nuclear_science_and_technology_organisation_corporate_plan.pdf)`\n- [Page 9]\n3 Our strategy and our priority activities\n3.1 STRATEGIC OBJECTIVE 1 –\nDeliver on Australia’s priorities for the benefit of people,\nindustry and the environment through nuclear excellence in\nresearch and the use of national infrastructure\n3.1.1 Deliver and translate research that has scientific and industrial impact for Australia Key activity Outcome 2022-2023 2023-2024 2024-2025 2025-2026\nUpdated ANSTO Translation of research into scientific and industrial impacts in\nThe Australian Government’s nine Science and Research Priorities, developed in consultation with industry, research and\nresearch and alignment with ANSTO’s new strategy.\ngovernment, are designed to focus support for science and research on the most important problems facing Australia.\n  Source: `corporate-plans/2022.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/77ebc9ab-c43d-4751-9e26-49a33639d1b5/2022-23_australian_nuclear_science_and_technology_organisation_corporate_plan.pdf)`\n- [Page 3]\nANSTO vision Contents\n1 Introduction 5\n1.1 A message from the Chair of the Board 5\n1.2 A message from the Chief Executive Officer 6\n2 Our organisation 8\n2.1 Our mission 8\n2.2 What we do 8\n2.3 Our capabilities 9\n2.4 Our people 10\n2.5 Our purpose 11\n2.6 Our values 12\n2.7 Our commitment to safety and community 13\n2.8 Our strategy in summary 16\n3 Our strategy and our priority activities 18\n3.1 STRATEGIC OBJECTIVE 1 –\nDeliver on Australia’s priorities for the benefit of people, industry and the environment through\nnuclear excellence in research and the use of national infrastructure 18\n3.2 STRATEGIC OBJECTIVE 2 –\nImprove the health of Australia by supporting access to current and future nuclear technologies\nfor diagnostic, therapeutic and innovative treatments for current and emerging diseases 30\n3.3 STRATEGIC OBJECTIVE 3 –\n  Source: `corporate-plans/2024.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/337594f0-dcaf-4f17-b733-b131b6b60bf3/2024-25%20Australian%20Nuclear%20Science%20and%20Technology%20Organisation%20Corporate%20Plan.pdf)`\n- [Page 18]\n3 Our strategy and our priority activities\n3.1 STRATEGIC OBJECTIVE 1 –\nDeliver on Australia’s priorities for the benefit of people,\nindustry and the environment through nuclear excellence\nin research and the use of national infrastructure\nOperate world-class research infrastructure and leverage capabilities to deliver\n3.1.1\noutcomes for Australia\nOur infrastructure places Australia at the forefront of translational nuclear research and innovation for the benefit of public health,\nindustry, and the environment.\n  Source: `corporate-plans/2024.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/337594f0-dcaf-4f17-b733-b131b6b60bf3/2024-25%20Australian%20Nuclear%20Science%20and%20Technology%20Organisation%20Corporate%20Plan.pdf)`\n- Deliver on Australia’s priorities for the benefit of people, industry and\nthe environment through nuclear excellence in research and the use of\nnational infrastructure.\n(Strategic Objective 1)\nANSTO Nuclear Medicine New South Wales In Budget 2023-24 the Government announced its decision to\nPty Ltd formally wind up ANSTO Nuclear Medicine Pty Ltd (ANM) by 1 July\n2024 and transfer its operations, assets and liabilities to ANSTO.\n  Source: `corporate-plans/2024.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/337594f0-dcaf-4f17-b733-b131b6b60bf3/2024-25%20Australian%20Nuclear%20Science%20and%20Technology%20Organisation%20Corporate%20Plan.pdf)`\n- STRATEGIC OBJECTIVE 1 –\nDeliver on Australia’s priorities for the benefit of people, industry and\nthe environment through nuclear excellence in research and the use\nof national infrastructure\nSTRATEGIC OBJECTIVE 2 –\nImprove the health of Australia by supporting access to current and\nfuture nuclear technologies for diagnostic, therapeutic and innovative\ntreatments for current and emerging diseases\nSTRATEGIC OBJECTIVE 3 –\nAustralia’s source of nuclear expertise, advice and services to\ngovernments, academia, industry and community\nSTRATEGIC OBJECTIVE 4 –\nLead the development of a nuclear-capable workforce aligned with\ngovernment policy objectives\n14 AANNSSTTOO CCoorrppoorraattee PPllaann 22002222 –– 22002266 1155\nContents\n  Source: `corporate-plans/2022.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/77ebc9ab-c43d-4751-9e26-49a33639d1b5/2022-23_australian_nuclear_science_and_technology_organisation_corporate_plan.pdf)`\n- [Page 3]\nContents\nIntroduction – A message from the Chair of the Board 4\nIntroduction – A message from the Chief Executive Officer 6\nVision 8\nValues 8\nWhat we do 8\nANSTO’s purpose 11\nANSTO’s operating environment 14\nInternational cooperation 18\nANSTO’s planning and performance process 20\nStrategic objectives 22\nMajor projects 46\nANSTO’s core capabilities 60\nGovernance and oversight of risk management 64\nANSTO Corporate Plan 2020 - 2021 3\n  Source: `corporate-plans/2020-21.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/c9be6c79-f727-452b-adc4-2533f6c9473e/ansto_corporate_plan_2020-2021.pdf)`\n- [Page 2]\nContents\n1 Introduction 5\n1.1 A message from the Chair of the Board 5\n1.2 A message from the Chief Executive Officer 6\n1.3 Vision 8\n1.4 What we do 8\n2 Our purpose and strategy 10\n2.1 Purpose 10\n2.2 Our strategy 11\n2.3 Our values 12\n2.4 Our organisation and people 14\n2.5 Portfolio Budget Statements, Corporate Plan and Annual Report 17\n3 Our operating environment 18\n3.1 National factors 18\n3.2 Global factors 22\n3.3 Cooperation and collaboration 24\n4 Strategy and key activities 26\n4.1 STRATEGIC IMPERATIVE 1 - Research and research infrastructure\nTo conduct research and enable external use of our research capability and infrastructure for the national benefit 26\n4.2 STRATEGIC IMPERATIVE 2 - Commercial products and services\nTo provide nuclear medicines and commercial services for the benefit of Australia and the world 36\n4.3 STRATEGIC IMPERATIVE 3 - Expert and trusted advisor\n  Source: `corporate-plans/2021-22.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/2e76500f-0714-43d1-9355-a720584b9972/2021-22_corporate_plan_australian_nuclear_science_and_technology_organisation.pdf)`\n- [Page 14]\nStrategy and key activities\n4\nKEY ACTIVITIES FOR 2021–2025:\n4.1 STRATEGIC IMPERATIVE 1 –\nHow we will deliver on our Strategy and Purpose\nResearch and research infrastructure\nFive-year R&D strategy for successful innovation in health\nTo conduct research and enable external use of our research capability This activity focuses on delivering improved health outcomes for all Australians through the effective application of radioisotopes\nand related technologies, including radiopharmaceuticals.\n  Source: `corporate-plans/2021-22.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/2e76500f-0714-43d1-9355-a720584b9972/2021-22_corporate_plan_australian_nuclear_science_and_technology_organisation.pdf)`\n- Over the next\nsustainability of nuclear medicine supply are considered by four years, ANSTO plans to reliably manufacture Mo-99 to meet\nGovernment. domestic demand as a primary priority, while seeking to increase\nKey activity Outcome 2021-2022 2022-2023 2023-2024 2024-2025\nits global market share.\n  Source: `corporate-plans/2021-22.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/2e76500f-0714-43d1-9355-a720584b9972/2021-22_corporate_plan_australian_nuclear_science_and_technology_organisation.pdf)`\n\n## KPIs, Targets, and Where They Are At\n\n- Measure\nProactive safety reporting\nYEARS TARGET\n2020-2021\nDemonstrated increase in the ratio of\n2021-2022\nreported Opportunities For Improvement\n(OFI) to Incidents in ANSTO’s Governance Risk\n2022-2023\nand Compliance (GRC) Reporting System\n2023-2024\n* OFI – An event that did not result in any adverse effects to personnel or the\nenvironment and is not considered to have had the potential to cause a lost\ntime injury, medical treatment injury or exposure of personnel, or harm to\nthe environment; but could have resulted in a minor occurrence or damage\nto plant and equipment.\n  Source: `corporate-plans/2020-21.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/c9be6c79-f727-452b-adc4-2533f6c9473e/ansto_corporate_plan_2020-2021.pdf)`\n- Key activities for 2022–2026:\nHow we will deliver on our strategy and purpose\nPerformance measure 2022-2023 2023-2024 2024-2025 2025-2026\nCampus Renewal Plan 2035 Developing an environmental sustainability strategy New jobs supported each year within the Innovation Precinct ≥360 ≥370 ≥380 ≥390\nThe Campus Renewal Plan 2035 is being developed with a focus Over the period covered by this Plan, ANSTO will implement a\non reviewing, developing, and consolidating the existing asset 15-year environmental sustainability roadmap that will result\nbase and business functions within ANSTO.\n  Source: `corporate-plans/2022.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/77ebc9ab-c43d-4751-9e26-49a33639d1b5/2022-23_australian_nuclear_science_and_technology_organisation_corporate_plan.pdf)`\n- As a result, a failure\nPerformance measure 2022-2023 2023-2024 2024-2025 2025-2026\nproject to design and build a new facility.\n  Source: `corporate-plans/2022.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/77ebc9ab-c43d-4751-9e26-49a33639d1b5/2022-23_australian_nuclear_science_and_technology_organisation_corporate_plan.pdf)`\n- P Preparation I Implementation C Completion M Monitoring and improving\nPerformance measure 2022-2023 2023-2024 2024-2025 2025-2026\nImprovement in safety culture Increase in opportunities for improvement (OFI)\nto actual incidents recorded*\nImprovement in site-wide safety Zero Class 1 incidents**\nYear on year decrease in Class 2 & 3 incidents***\n* OFI – An event that did not result in any adverse effects to personnel or the environment and is not considered to have had the potential to cause a lost time injury,\nmedical treatment injury or exposure of personnel, or harm to the environment; but could have resulted in a minor occurrence or damage to plant and equipment.\n** Class 1 – Damage that permanently alters a person’s life\n*** Class 2 – Damage that temporarily alters a person’s life\nClass 3 – Inconveniences in person’s life or 1–5 days/shifts off work.\n  Source: `corporate-plans/2022.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/77ebc9ab-c43d-4751-9e26-49a33639d1b5/2022-23_australian_nuclear_science_and_technology_organisation_corporate_plan.pdf)`\n- Performance criterion Measure 2020-2021 2021-2022 2022-2023 2023-2024\nShare with the general public\nScience stories to highlight ANSTO’s ≥ 36 science stories published\nresearch outcomes enabled\nresearch outcomes on the ANSTO website per annum\nby ANSTO\nOffer a range of resources for teachers and\nDeliver ≥ six national programs\nstudents to support the national science\nper annum\ncurriculum outcomes for years 3 to 12\nIncrease accessibility of STEMM teacher\nDeliver teacher professional development days\nIncrease STEM engagement training programs\nin all states and territories\nConduct educational tours and science\n≥ 5,000* ≥ 15,000 ≥ 15,000 ≥ 15,000\nexperiences at ANSTO’s Sydney and\nvisitors to ANSTO’s campuses per annum\nMelbourne campuses.\n* 2020-2021 has a reduced target due to the COVID-19 pandemic.\n  Source: `corporate-plans/2020-21.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/c9be6c79-f727-452b-adc4-2533f6c9473e/ansto_corporate_plan_2020-2021.pdf)`\n- [Page 18]\nKey activity Outcome 2021-2022 2022-2023 2023-2024 2024-2025 Performance measure 2021-2022 2022-2023 2023-2024 2024-2025\nOPAL multi-purpose reactor upgrades OPAL OPAL will continue its strong record of performance, retaining\n(Days at power) its status as one of the most reliable multi-purpose reactors in 290 300 220* 300\nReplacement of Cold Neutron Source Ensure the ongoing and safe operation of P I C M the world.\nthe OPAL reactor and optimally position\nReplacement and expansion of ANSTO to supply radioisotopes reliably, Australian Synchrotron The Australian Synchrotron is one of the leading synchrotron\nneutron beams undertake effective silicon irradiations (% utilisation) facilities of its kind, maximising utilisation to deliver\nI C M M\nand deliver neutrons for research and beneficial research outcomes for Australia.\n  Source: `corporate-plans/2021-22.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/2e76500f-0714-43d1-9355-a720584b9972/2021-22_corporate_plan_australian_nuclear_science_and_technology_organisation.pdf)`\n- How we will deliver on our strategy and purpose\nP Preparation I Implementation C Completion M Monitoring and improving\nUpdated ANSTO research and development Current Research Information System and Portal\nstrategy and implementation (CRISP) project\nTranslating our research into scientific and industrial impacts The CRISP project will provide our organisation with best Performance measure 2022-2023 2023-2024 2024-2025 2025-2026\nis a priority for ANSTO.\n  Source: `corporate-plans/2022.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/77ebc9ab-c43d-4751-9e26-49a33639d1b5/2022-23_australian_nuclear_science_and_technology_organisation_corporate_plan.pdf)`\n- [Page 11]\nKey activity Outcome 2022-2023 2023-2024 2024-2025 2025-2026 Performance measure 2022-2023 2023-2024 2024-2025 2025-2026\nOPAL multi-purpose reactor upgrades OPAL OPAL will continue its strong record of performance, retaining\n(Days at power) its status as one of the most reliable multi-purpose reactors in 290 300 220* 300\nReplacement of CNS Ensure the ongoing and safe operation of P I C M the world.\nthe OPAL nuclear reactor and optimally\nReplacement and expansion of position ANSTO to supply radioisotopes Australian Synchrotron The Australian Synchrotron is one of the leading synchrotron\nneutron beams reliably, undertake effective silicon (% utilisation) facilities of its kind, maximising utilisation to deliver\nM M M M\nirradiations, and deliver neutrons for beneficial research outcomes for Australia.\n  Source: `corporate-plans/2022.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/77ebc9ab-c43d-4751-9e26-49a33639d1b5/2022-23_australian_nuclear_science_and_technology_organisation_corporate_plan.pdf)`\n- Key activity Outcome 2022-2023 2023-2024 2024-2025 2025-2026 Performance measure 2022-2023 2023-2024 2024-2025 2025-2026\nDevelop and implement world-leading Construction of a world-first Synroc® Waste NTD silicon DIFOT* OPAL will continue its strong record of performance,\ninnovative radioactive waste treatment Treatment Plant to ensure liquid waste retaining its status as one of the most reliable multi-purpose ≥ 95% ≥ 95% ≥ 95% ≥ 95%\nand management technologies by-products from the manufacture of I I C M reactors in the world.\n  Source: `corporate-plans/2022.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/77ebc9ab-c43d-4751-9e26-49a33639d1b5/2022-23_australian_nuclear_science_and_technology_organisation_corporate_plan.pdf)`\n- Performance measure 2022-2023 2023-2024 2024-2025 2025-2026\nKey activities for 2022–2026:\nAustralian Government stakeholder satisfaction – federal, state and local government 75% 75% 75% 75% How we will deliver on our strategy and purpose\nCase studies to highlight and assess the impact of our engagement with Chairing the Regional Cooperative Agreement (RCA)\n≥ Four case studies per annum\ngovernment-related stakeholders\nAustralia, through ANSTO, will serve as the Chair of the RCA in 2023.\n  Source: `corporate-plans/2022.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/77ebc9ab-c43d-4751-9e26-49a33639d1b5/2022-23_australian_nuclear_science_and_technology_organisation_corporate_plan.pdf)`\n- [Page 11]\nKey activity Outcome 2023-2024 2024-2025 2025-2026 2026-2027 Performance measure 2023-2024 2024-2025 2025-2026 2026-2027\nOPAL multi-purpose reactor upgrades OPAL OPAL will continue its strong record of performance, retaining\n(Days at power) its status as one of the most reliable multi-purpose reactors in 220* 300 300 300\nReplacement of CNS Ensure the ongoing and safe operation of I C M M the world.\nthe OPAL nuclear reactor and optimally\nReplacement and expansion of position ANSTO to supply radioisotopes Australian Synchrotron The Australian Synchrotron is one of the leading synchrotron\nneutron beams reliably, undertake effective silicon (% utilisation) facilities of its kind, maximising utilisation to deliver\nM M M M\nirradiations, and deliver neutrons for beneficial research outcomes for Australia.\n  Source: `corporate-plans/2023.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/29b98a52-490e-47e4-99a5-aef2ceb2fc8a/2023-24_australian_nuclear_science_and_technology_organisation_corporate_plan.pdf)`\n- In the 2023-24 Budget the Commonwealth nuclear medicines from the current facility a significant redesign of\nGovernment announced funding to construct a new nuclear maintenance strategies and capital improvement plans is required.\nmedicine manufacturing facility and to support the continued An assessment of the facility and its systems is being undertaken\nPerformance measure 2023-2024 2024-2025 2025-2026 2026-2027\nproduction of nuclear medicine in the existing facility pending to determine the most appropriate maintenance strategy.\ncompletion of the replacement project.\n  Source: `corporate-plans/2023.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/29b98a52-490e-47e4-99a5-aef2ceb2fc8a/2023-24_australian_nuclear_science_and_technology_organisation_corporate_plan.pdf)`\n- Conduct educational tours and science experiences at ANSTO’s ≥ 15,000 ≥ 15,000 ≥ 15,000 ≥ 15,000\nMeasuring performance: Sydney and Melbourne campuses\nvisitors to ANSTO’s campuses per annum\nPerformance measure 2023-2024 2024-2025 2025-2026 2026-2027\nFacilitation of Australian participation and leadership RCA: Participation in 80 per cent of active projects,\nin IAEA and RCA programs leading ≥1 project\nIAEA CRP: Participate in ≥10 projects relevant to\nnuclear applications\nKey activities for 2023–2027:\nHow we will deliver on our strategy and purpose\nChairing the Regional Cooperative Agreement (RCA)\nThe RCA is a treaty level agreement between 22 counties promote gender parity strategies as we strive to achieve gender\nrun under the auspices of the International Atomic Energy equality in the field of nuclear science and technology in our\nAgency (IAEA) Technical Cooperation programme.\n  Source: `corporate-plans/2023.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/29b98a52-490e-47e4-99a5-aef2ceb2fc8a/2023-24_australian_nuclear_science_and_technology_organisation_corporate_plan.pdf)`\n- Measuring performance and targets:\nPerformance measure 2022-2023 2023-2024 2024-2025 2025-2026\nLeadership teams – representation Female 40% | Male 40% | Discretionary 20%\nANSTO-wide – representation Female 40% | Male 40% | Discretionary 20%\nPsychological safety culture program\nPsychological safety for our workforce is an important priority for ANSTO.\n  Source: `corporate-plans/2023.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/29b98a52-490e-47e4-99a5-aef2ceb2fc8a/2023-24_australian_nuclear_science_and_technology_organisation_corporate_plan.pdf)`\n\n## Key Metrics\n\n| Values found | Evidence | Source |\n|---|---|---|\n| $43.2 million, 43.2 million | 2022 operating environment continues to\n4.2.3 Peaceful applications of\nbe challenging, with the COVID-19 pandemic\nThe 2022–23 Australian Budget also contained $43.2 million to support capital significantly reducing the returns from ANSTO’s nuclear science and technology\nprograms, primarily relating to the production of nuclear medicine commercial revenue streams. | `corporate-plans/2022.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/77ebc9ab-c43d-4751-9e26-49a33639d1b5/2022-23_australian_nuclear_science_and_technology_organisation_corporate_plan.pdf)` |\n| $318.4 million, $153.9 million, 318.4 million, 153.9 million | For 2024-25, the Budget provided $318.4 million to support ANSTO’s achievement of its purpose, goals, and objectives, in addition to the\n$153.9 million forecast for our own source revenue, primarily from the sale of nuclear medicine and other activities. | `corporate-plans/2024.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/337594f0-dcaf-4f17-b733-b131b6b60bf3/2024-25%20Australian%20Nuclear%20Science%20and%20Technology%20Organisation%20Corporate%20Plan.pdf)` |\n| $318.5 million, 200 staff, 318.5 million | Over one-third of ANSTO’s workforce resides in the Sutherland Shire and approximately 200 staff are employed at For 2023-24, the Australian Budget delivered $318.5 million to support ANSTO’s achievement of its purpose, goals, and objectives,\nANSTO’s Clayton campus, home to the Australian Synchrotron. | `corporate-plans/2023.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/29b98a52-490e-47e4-99a5-aef2ceb2fc8a/2023-24_australian_nuclear_science_and_technology_organisation_corporate_plan.pdf)` |\n| $116.7 million, 116.7 million | In the 2021-22 Budget, ANSTO remains a challenge that is being affected by\ncommunities, staff and other Indigenous received a funding package of $116.7 million, to be paid over a four-year period. both external and internal factors. | `corporate-plans/2021-22.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/2e76500f-0714-43d1-9355-a720584b9972/2021-22_corporate_plan_australian_nuclear_science_and_technology_organisation.pdf)` |\n| $25.9 million, 25.9 million | The 2024-25 Budget allocated ANSTO $25.9 million over two years from 2024-25 to continue production of affordable nuclear medicine. | `corporate-plans/2024.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/337594f0-dcaf-4f17-b733-b131b6b60bf3/2024-25%20Australian%20Nuclear%20Science%20and%20Technology%20Organisation%20Corporate%20Plan.pdf)` |\n| $1 billion, 1 billion | [Page 10]\nWe manage over\n$1 billion worth of\nWe employ just\nlandmark infrastructure\nunder 1,400 people\nand scientific assets, including some\nin Australia\nof Australia’s most sophisticated\nresearch infrastructure\nWe deliver more than We have two\n12,500 patient doses main campuses\nof nuclear medicine in Lucas Heights (NSW) and Clayton (VIC).\nto over 250 hospitals and medical We also work from and operate a facility\npractices across Australia every | `corporate-plans/2020-21.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/c9be6c79-f727-452b-adc4-2533f6c9473e/ansto_corporate_plan_2020-2021.pdf)` |\n| $289.8 million, 289.8 million | The 2022–23 Australian Budget remains a challenge that is being impacted affected both ANSTO’s ability to receive and supply product in Australia and its\ndelivered $289.8 million to support ANSTO’s achievement of its goals and objectives, by both external and internal factors. | `corporate-plans/2022.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/77ebc9ab-c43d-4751-9e26-49a33639d1b5/2022-23_australian_nuclear_science_and_technology_organisation_corporate_plan.pdf)` |\n| $5.5 M, $5.75 M, $6 M, 95 per cent | This will be supported by implementing the Research Infrastructure Management Strategy Publications undertaken with national and international collaborators ≥95 per cent\nprocess improvements to systems which are tailored to research (RIMS) and gathering requirements for the future state ANSTO\nand development, including finance management, IT data Research Portal, the gateway to submission of research proposals External revenue from research and r | `corporate-plans/2023.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/29b98a52-490e-47e4-99a5-aef2ceb2fc8a/2023-24_australian_nuclear_science_and_technology_organisation_corporate_plan.pdf)` |\n| $39.9 million, 39.9 million | You can read more about the OPAL 2024 shutdown here.\n. $39.9 million over 3 years from 2023-24 to formally wind-up ANSTO Nuclear Medicine Pty Ltd by 1 July 2024 and transfer its operations,\nassets, and liabilities to ANSTO, enabling streamlining of governance and expertise. | `corporate-plans/2023.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/29b98a52-490e-47e4-99a5-aef2ceb2fc8a/2023-24_australian_nuclear_science_and_technology_organisation_corporate_plan.pdf)` |\n| $5.5 M, 95 per cent | [Page 25]\nKey activity Outcome 2024-2025 2025-2026 2026-2027 2027-2028\nUpdated ANSTO Improved health outcomes for all Australians through the\nresearch and effective application of radioisotopes and radioisotope-enabled\nI I I I\ndevelopment strategy technologies, including radiopharmaceuticals.\nand implementation\nCRISP project\nResearch Information\nManagement System I C M M\n(RIMS)\nLaboratory Information\nManagement System I I C M\n(LIMS)\nP Preparation | `corporate-plans/2024.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/337594f0-dcaf-4f17-b733-b131b6b60bf3/2024-25%20Australian%20Nuclear%20Science%20and%20Technology%20Organisation%20Corporate%20Plan.pdf)` |\n| $59.8 million, 59.8 million | Aboriginal knowledge and current scientific and technological practice. will allow us to continue to maintain our critical assets and progress our site\nrenewal plans; and That decrease has also been exacerbated by\nnuclear medicine supply disruptions, which\n3.1.6 Radioactive waste management . $59.8 million for the construction of an interim intermediate level solid waste have reduced export income and required\nstorage facility. | `corporate-plans/2021-22.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/2e76500f-0714-43d1-9355-a720584b9972/2021-22_corporate_plan_australian_nuclear_science_and_technology_organisation.pdf)` |\n| $141.6 million, 141.6 million | Community engagement is a strong priority at ANSTO through in addition to the $141.6 million forecasted for our own source revenue, primarily from the sale of nuclear medicine. | `corporate-plans/2023.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/29b98a52-490e-47e4-99a5-aef2ceb2fc8a/2023-24_australian_nuclear_science_and_technology_organisation_corporate_plan.pdf)` |\n| 80 per cent | Conduct educational tours and science experiences at ANSTO’s ≥ 15,000 ≥ 15,000 ≥ 15,000 ≥ 15,000\nMeasuring performance: Sydney and Melbourne campuses\nvisitors to ANSTO’s campuses per annum\nPerformance measure 2023-2024 2024-2025 2025-2026 2026-2027\nFacilitation of Australian participation and leadership RCA: Participation in 80 per cent of active projects,\nin IAEA and RCA programs leading ≥1 project\nIAEA CRP: Participate in ≥10 projects relevant | `corporate-plans/2023.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/29b98a52-490e-47e4-99a5-aef2ceb2fc8a/2023-24_australian_nuclear_science_and_technology_organisation_corporate_plan.pdf)` |\n| 80 per cent | Measuring performance:\nPerformance measure 2024-2025 2025-2026 2026-2027 2027-2028\nFacilitation of Australian participation and leadership RCA: Participation in 80 per cent of active projects,\nin IAEA and RCA programs leading ≥1 project\nIAEA CRP: Participate in ≥10 projects relevant to\nnuclear applications\nKey activities for 2024–2028:\nHow we will deliver on our strategy and purpose\nLeadership in setting global nuclear standards Leading impactful | `corporate-plans/2024.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/337594f0-dcaf-4f17-b733-b131b6b60bf3/2024-25%20Australian%20Nuclear%20Science%20and%20Technology%20Organisation%20Corporate%20Plan.pdf)` |\n\n## Key Achievements\n\n- Over one-third of ANSTO’s workforce resides in the Sutherland Shire and approximately 200 staff are employed at For 2023-24, the Australian Budget delivered $318.5 million to support ANSTO’s achievement of its purpose, goals, and objectives,\nANSTO’s Clayton campus, home to the Australian Synchrotron.\n  Source: `corporate-plans/2023.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/29b98a52-490e-47e4-99a5-aef2ceb2fc8a/2023-24_australian_nuclear_science_and_technology_organisation_corporate_plan.pdf)`\n- The 2022–23 Australian Budget remains a challenge that is being impacted affected both ANSTO’s ability to receive and supply product in Australia and its\ndelivered $289.8 million to support ANSTO’s achievement of its goals and objectives, by both external and internal factors.\n  Source: `corporate-plans/2022.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/77ebc9ab-c43d-4751-9e26-49a33639d1b5/2022-23_australian_nuclear_science_and_technology_organisation_corporate_plan.pdf)`\n- Annual report 2023-2024\nView 2023-24 Annual report\nAnnual report 2022-2023\nView 2022-23 Annual report\nAnnual report 2021-2022\nView 2021-22 Annual report\nAnnual report 2020-2021\nView 2020-21 Annual report\nA\nnnual report 2019-2020\nView 2019-20 Annual report\nAnnual report 2018-2019\nView 2018-19 Annual report\nDownload PDF (9.5 MB)\nAnnual Report 2017-2018\nHighlights from the 2017-2018 annual report include progress on the Innovation precinct and funding to expand the Australian Synchrotron beamlines.\n  Source: `pages/corporate-plans-index.html (http://www.ansto.gov.au/Resources/Publications/CorporatePlan/index.htm)`\n- Performance criterion Measure 2020-2021 2021-2022 2022-2023 2023-2024\nShare with the general public\nScience stories to highlight ANSTO’s ≥ 36 science stories published\nresearch outcomes enabled\nresearch outcomes on the ANSTO website per annum\nby ANSTO\nOffer a range of resources for teachers and\nDeliver ≥ six national programs\nstudents to support the national science\nper annum\ncurriculum outcomes for years 3 to 12\nIncrease accessibility of STEMM teacher\nDeliver teacher professional development days\nIncrease STEM engagement training programs\nin all states and territories\nConduct educational tours and science\n≥ 5,000* ≥ 15,000 ≥ 15,000 ≥ 15,000\nexperiences at ANSTO’s Sydney and\nvisitors to ANSTO’s campuses per annum\nMelbourne campuses.\n* 2020-2021 has a reduced target due to the COVID-19 pandemic.\n  Source: `corporate-plans/2020-21.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/c9be6c79-f727-452b-adc4-2533f6c9473e/ansto_corporate_plan_2020-2021.pdf)`\n- Expert and trusted advisor\ninfrastructure services\nEnabling Focus Key\nobjectives areas* activities*\nTo conduct research and enable external To provide nuclear medicines and To be an expert and trusted advisor to\nuse of our research capability and commercial services for the benefit of Government, industry, international\ninfrastructure for the national benefit Australia and the world partners and the Australian public\n* Outlined in Section 4 of the 2021–2022 Corporate Plan\nDeliver and translate research that has Ensure the reliable and sustainable supply Deliver expert advice to Local, State,\nscientific and industry impact, with a focus of nuclear medicines, products and services and Federal Governments and related\n2.1 Purpose on health, the environment and the nuclear stakeholders in support of organisational\nfuel cycle and national interests\n  Source: `corporate-plans/2021-22.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/2e76500f-0714-43d1-9355-a720584b9972/2021-22_corporate_plan_australian_nuclear_science_and_technology_organisation.pdf)`\n- [Page 13]\nEnsure ANSTO operates sustainably Use knowledge incubation, research translation and collaboration within the\n3.1.6 3.1.7\nInnovation Precinct to produce real-world benefits\nWe will continue to ensure the sustainability of our operations by:\nANSTO’s Innovation Centre, nandin, brings science and technology entrepreneurs, start-ups and graduates together to challenge,\ncommitting to the achievement of a balanced budget safely and responsibly managing our radioactive waste design, innovate and commercialise, creating new jobs in the high-growth industries of tomorrow. nandin is home to a vibrant\ncommunity of 30 member businesses who work to develop ingenious solutions to solve as yet unmet challenges in our world.\n  Source: `corporate-plans/2022.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/77ebc9ab-c43d-4751-9e26-49a33639d1b5/2022-23_australian_nuclear_science_and_technology_organisation_corporate_plan.pdf)`\n- ANSTO has a thorough Asset Management Plan that will be\nNuclear Medicine Production Facility DIFOT >95% >95% >95% >95%\nThe design and planning phase will take place in 2022–23 and implemented over the remaining lifetime of the Nuclear\nwill provide the gateway to the establishment of a purpose-built Medicine Production Facility.\n  Source: `corporate-plans/2022.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/77ebc9ab-c43d-4751-9e26-49a33639d1b5/2022-23_australian_nuclear_science_and_technology_organisation_corporate_plan.pdf)`\n- Performance measure 2022-2023 2023-2024 2024-2025 2025-2026\nKey activities for 2022–2026:\nAustralian Government stakeholder satisfaction – federal, state and local government 75% 75% 75% 75% How we will deliver on our strategy and purpose\nCase studies to highlight and assess the impact of our engagement with Chairing the Regional Cooperative Agreement (RCA)\n≥ Four case studies per annum\ngovernment-related stakeholders\nAustralia, through ANSTO, will serve as the Chair of the RCA in 2023.\n  Source: `corporate-plans/2022.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/77ebc9ab-c43d-4751-9e26-49a33639d1b5/2022-23_australian_nuclear_science_and_technology_organisation_corporate_plan.pdf)`\n- Key activities for 2024–2028:\nHow we will deliver on our strategy and purpose\nNuclear Medicine Manufacturing Facility (NMMF)\nIn the 2023-24 Budget, and following the September 2023 In the 2023-24 period, this project saw rapid progress: the\nMinister’s announcement, the Commonwealth Government establishment of a strong governance framework through the\nconfirmed funding to construct a new Nuclear Medicine ANSTO NMMF Steering Committee; publication of a request\nManufacturing Facility and to secure a reliable and sovereign for tender via Austender; engagement with critical European\nnuclear medicine supply chain.\n  Source: `corporate-plans/2024.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/337594f0-dcaf-4f17-b733-b131b6b60bf3/2024-25%20Australian%20Nuclear%20Science%20and%20Technology%20Organisation%20Corporate%20Plan.pdf)`\n- For 2024-25, the Budget provided $318.4 million to support ANSTO’s achievement of its purpose, goals, and objectives, in addition to the\n$153.9 million forecast for our own source revenue, primarily from the sale of nuclear medicine and other activities.\n  Source: `corporate-plans/2024.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/337594f0-dcaf-4f17-b733-b131b6b60bf3/2024-25%20Australian%20Nuclear%20Science%20and%20Technology%20Organisation%20Corporate%20Plan.pdf)`\n- We will\nPerformance measure 2021-2022 2022-2023 2023-2024 2024-2025\nAustralian Government Stakeholder Satisfaction –\n75% 75% 75% 75%\nFederal, State and Local Government Performance measure 2021-2022 2022-2023 2023-2024 2024-2025\nCase Studies to highlight and assess the impact of our Facilitation of Australian participation and leadership in IAEA and RCA programs\n≥ Four case studies per annum\nengagement with Government-related stakeholders\nRCA Participation in 80% of active projects, leading ≥1 project\nIAEA CRP Participate in ≥10 projects relevant to nuclear applications\nCase studies to highlight and assess the impact of our engagement\n≥ Two case studies per annum\nwith international stakeholders\n40 ANSTO Corporate Plan 2021 – 2022 41\nContents\n  Source: `corporate-plans/2021-22.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/2e76500f-0714-43d1-9355-a720584b9972/2021-22_corporate_plan_australian_nuclear_science_and_technology_organisation.pdf)`\n- Measuring performance:\nPerformance measure 2022-2023 2023-2024 2024-2025 2025-2026\nFacilitation of Australian participation and leadership RCA:\nin IAEA and RCA programs Participation in 80 per cent of active projects,\nleading ≥1 project\nIAEA CRP:\nParticipate in ≥10 projects relevant to\nnuclear applications\nCase studies to highlight and assess the impact of our\n≥ Two case studies per annum\nengagement with international stakeholders\n28 ANSTO Corporate Plan 2022 – 2026 29\nContents\n  Source: `corporate-plans/2022.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/77ebc9ab-c43d-4751-9e26-49a33639d1b5/2022-23_australian_nuclear_science_and_technology_organisation_corporate_plan.pdf)`\n\n## Key Issues, Risks, and Recommendations\n\n- [Page 3]\nContents\nIntroduction – A message from the Chair of the Board 4\nIntroduction – A message from the Chief Executive Officer 6\nVision 8\nValues 8\nWhat we do 8\nANSTO’s purpose 11\nANSTO’s operating environment 14\nInternational cooperation 18\nANSTO’s planning and performance process 20\nStrategic objectives 22\nMajor projects 46\nANSTO’s core capabilities 60\nGovernance and oversight of risk management 64\nANSTO Corporate Plan 2020 - 2021 3\n  Source: `corporate-plans/2020-21.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/c9be6c79-f727-452b-adc4-2533f6c9473e/ansto_corporate_plan_2020-2021.pdf)`\n- [Page 12]\nOur people\nNuclear Nuclear Science & Technology\nPrecint and Landmark Infrastructure\n399 332\n29% 24%\nANSTO Maintenance Research Translation\nand Engineering and Synchrotron\n180 142\n13% 10%\nChief Operating Officer Information\nGroup Governance, Risk and Compliance Technology\nRegulatory and Safety Assurance\n136 Legal Services 64\nFinance\nHigh Reliability\n10% Government and International Affairs 5%\nMarkets and People, Culture\nBusiness Excellence and Security\n49 46\n4% 4%\nOffice of\nthe CEO TOTAL\n8\n1,356\n1%\nANSTO’s Average Staffing\nLevel (ASL) is 1,282\n12\nContents\n  Source: `corporate-plans/2020-21.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/c9be6c79-f727-452b-adc4-2533f6c9473e/ansto_corporate_plan_2020-2021.pdf)`\n- Measure\nProactive safety reporting\nYEARS TARGET\n2020-2021\nDemonstrated increase in the ratio of\n2021-2022\nreported Opportunities For Improvement\n(OFI) to Incidents in ANSTO’s Governance Risk\n2022-2023\nand Compliance (GRC) Reporting System\n2023-2024\n* OFI – An event that did not result in any adverse effects to personnel or the\nenvironment and is not considered to have had the potential to cause a lost\ntime injury, medical treatment injury or exposure of personnel, or harm to\nthe environment; but could have resulted in a minor occurrence or damage\nto plant and equipment.\n  Source: `corporate-plans/2020-21.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/c9be6c79-f727-452b-adc4-2533f6c9473e/ansto_corporate_plan_2020-2021.pdf)`\n- Framework (ERMF) (see Figure 3), which provides the overall\n1 2 3 4 5\nDirection by Tools to Empower Measure risk Assurance to\nBoard enable people management stakeholders\nperformance\nFIGURE 3 ANSTO Enterprise Risk Management Framework\nOur risk management process\nANSTO’s innovative risk management process outlines how To ensure a consistent approach to risk management across the\nwe manage risk on a day-to-day basis.\n  Source: `corporate-plans/2020-21.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/c9be6c79-f727-452b-adc4-2533f6c9473e/ansto_corporate_plan_2020-2021.pdf)`\n- [Page 2]\nContents\n1 Introduction 5\n1.1 A message from the Chair of the Board 5\n1.2 A message from the Chief Executive Officer 6\n1.3 Vision 8\n1.4 What we do 8\n2 Our purpose and strategy 10\n2.1 Purpose 10\n2.2 Our strategy 11\n2.3 Our values 12\n2.4 Our organisation and people 14\n2.5 Portfolio Budget Statements, Corporate Plan and Annual Report 17\n3 Our operating environment 18\n3.1 National factors 18\n3.2 Global factors 22\n3.3 Cooperation and collaboration 24\n4 Strategy and key activities 26\n4.1 STRATEGIC IMPERATIVE 1 - Research and research infrastructure\nTo conduct research and enable external use of our research capability and infrastructure for the national benefit 26\n4.2 STRATEGIC IMPERATIVE 2 - Commercial products and services\nTo provide nuclear medicines and commercial services for the benefit of Australia and the world 36\n4.3 STRATEGIC IMPERATIVE 3 - Expert and trusted advisor\n  Source: `corporate-plans/2021-22.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/2e76500f-0714-43d1-9355-a720584b9972/2021-22_corporate_plan_australian_nuclear_science_and_technology_organisation.pdf)`\n- Operating context\nEnvironment -\n18-23\nThe environment in which the entity will operate\nCapability -\n52-55\nThe capability required by the entity to undertake its key activities and to achieve its purposes\nRisk Oversight and Management -\nThe risk oversight and management systems, the key risks the entity will manage and how those 56-61\nrisks will be managed\nCooperation -\n24\nHow an entity cooperates with others to achieve its purposes\nSubsidiaries -\n16, 36\nHow any subsidiaries will contribute to achieving the entity’s purposes\nPerformance\nThe Corporate Plan must set out the details of how an entity’s performance in achieving its\n17, 27-28, 35, 37, 39, 40, 41-42, 44-45, 47, 50\npurposes will be measured and assessed for each reporting period covered by the plan.\n  Source: `corporate-plans/2021-22.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/2e76500f-0714-43d1-9355-a720584b9972/2021-22_corporate_plan_australian_nuclear_science_and_technology_organisation.pdf)`\n- [Page 2]\nANSTO vision Contents\n1 Introduction 5\n1.1 A message from the Chair of the Board 5\nNuclear science and\n1.2 A message from the Chief Executive Officer 6\n2 Our organisation 8\n2.1 What we do 8\ntechnology for the\n2.2 Purpose 9\n2.3 Our people 10\nbenefit of all Australians 2.4 Our values 11\n2.5 Safety culture 12\n2.6 Our traditional owners 13\n2.7 Our strategy in summary 14\n3 Our strategy and our priority activities 16\n3.1 STRATEGIC OBJECTIVE 1 –\nDeliver on Australia’s priorities for the benefit of people, industry and the environment through\nnuclear excellence in research and the use of national infrastructure 16\n3.2 STRATEGIC OBJECTIVE 2 –\nImprove the health of Australia by supporting access to current and future nuclear technologies\nfor diagnostic, therapeutic and innovative treatments for current and emerging diseases 26\n3.3 STRATEGIC OBJECTIVE 3 –\n  Source: `corporate-plans/2022.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/77ebc9ab-c43d-4751-9e26-49a33639d1b5/2022-23_australian_nuclear_science_and_technology_organisation_corporate_plan.pdf)`\n- [Page 13]\nEnsure ANSTO operates sustainably Use knowledge incubation, research translation and collaboration within the\n3.1.6 3.1.7\nInnovation Precinct to produce real-world benefits\nWe will continue to ensure the sustainability of our operations by:\nANSTO’s Innovation Centre, nandin, brings science and technology entrepreneurs, start-ups and graduates together to challenge,\ncommitting to the achievement of a balanced budget safely and responsibly managing our radioactive waste design, innovate and commercialise, creating new jobs in the high-growth industries of tomorrow. nandin is home to a vibrant\ncommunity of 30 member businesses who work to develop ingenious solutions to solve as yet unmet challenges in our world.\n  Source: `corporate-plans/2022.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/77ebc9ab-c43d-4751-9e26-49a33639d1b5/2022-23_australian_nuclear_science_and_technology_organisation_corporate_plan.pdf)`\n- Operating context\nEnvironment -\n38-41\nThe environment in which the entity will operate\nCapability -\n44\nThe capability required by the entity to undertake its key activities and to achieve its purposes\nRisk Management -\n46-51\nCooperation -\n42-43\nHow an entity cooperates with others to achieve its purposes\nSubsidiaries -\n36\nHow any subsidiaries will contribute to achieving the entity’s purposes\nPerformance\nThe Corporate Plan must set out the details of how an entity’s performance in achieving its\n17, 21, 23, 25, 27, 28-30, 32-34, 37\npurposes will be measured and assessed for each reporting period covered by the plan.\n  Source: `corporate-plans/2022.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/77ebc9ab-c43d-4751-9e26-49a33639d1b5/2022-23_australian_nuclear_science_and_technology_organisation_corporate_plan.pdf)`\n- [Page 3]\nANSTO vision Contents\n1 Introduction 5\n1.1 A message from the Chair of the Board 5\n1.2 A message from the Chief Executive Officer 6\n2 Our organisation 8\n2.1 Our mission 8\n2.2 What we do 8\n2.3 Our capabilities 9\n2.4 Our people 10\n2.5 Our purpose 11\n2.6 Our values 12\n2.7 Our commitment to safety and community 13\n2.8 Our strategy in summary 16\n3 Our strategy and our priority activities 18\n3.1 STRATEGIC OBJECTIVE 1 –\nDeliver on Australia’s priorities for the benefit of people, industry and the environment through\nnuclear excellence in research and the use of national infrastructure 18\n3.2 STRATEGIC OBJECTIVE 2 –\nImprove the health of Australia by supporting access to current and future nuclear technologies\nfor diagnostic, therapeutic and innovative treatments for current and emerging diseases 30\n3.3 STRATEGIC OBJECTIVE 3 –\n  Source: `corporate-plans/2024.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/337594f0-dcaf-4f17-b733-b131b6b60bf3/2024-25%20Australian%20Nuclear%20Science%20and%20Technology%20Organisation%20Corporate%20Plan.pdf)`\n- Operating context\nEnvironment -\n40-42\nThe environment in which the entity will operate\nCapability -\n9-10\nThe capability required by the entity to undertake its key activities and to achieve its purposes\nRisk Management\n46-49\nCooperation -\n43\nHow an entity cooperates with others to achieve its purposes\nSubsidiaries -\n45\nHow any subsidiaries will contribute to achieving the entity’s purposes\nPerformance\nThe Corporate Plan must set out the details of how an entity’s performance in achieving its\n14, 23, 25, 27, 31, 33, 34-35, 37-38, 44\npurposes will be measured and assessed for each reporting period covered by the plan.\n  Source: `corporate-plans/2024.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/337594f0-dcaf-4f17-b733-b131b6b60bf3/2024-25%20Australian%20Nuclear%20Science%20and%20Technology%20Organisation%20Corporate%20Plan.pdf)`\n- OVERSIGHT AND GOVERNANCE\n• The Board retains overall accountability for the governance and risk and Board and\neffective risk management\nBoard Committees\n• The Board reviews and assesses the integrity of the risk management processes,\nand in conjunction with the Risk & Audit Committee, ensures that these processes\ncomply with the relevant governance requirements and standards\nGroup Executive\nBUSINESS AND STRATEGIC RISK MANAGEMENT\n• Executives are responsible and accountable for the governance of risks with\ndelegated responsibility and ownership to their respective line managers\nANSTO’s Enterprise Risk Management Framework\nANSTO’s Risk Appetite Framework\nDivisions and\nGroup functions\nDAY-TO-DAY RISK MANAGEMENT\n• Oversight of risk management at business unit level is the responsibility\nof the line management\n• Assurance providers1 provide assurance on the management of significant\n  Source: `corporate-plans/2020-21.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/c9be6c79-f727-452b-adc4-2533f6c9473e/ansto_corporate_plan_2020-2021.pdf)`\n- We will also share our learnings and accelerate * OFI – An event that did not result in any adverse effects to personnel or the environment and is not considered to have had the potential to cause a lost time injury,\nWe will reduce safety risks throughout the organisation by improvements amongst our state, territory and international medical treatment injury or exposure of personnel, or harm to the environment; but could have resulted in a minor occurrence or damage to plant and equipment.\nimplementing early intervention and response programs, partners, which will assist them in achieving sustainable safety ** Class 1 – Damage that permanently alters a person’s life; Class 2 – Damage that temporarily alters a person’s life; Class 3 -–Inconveniences in person’s life or 1-5\noccupational hygiene programs, targeted training, capital and security for radiological and nuclear activities.\n  Source: `corporate-plans/2021-22.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/2e76500f-0714-43d1-9355-a720584b9972/2021-22_corporate_plan_australian_nuclear_science_and_technology_organisation.pdf)`\n- These photographs were taken either before\nthe emergence of the COVID-19 pandemic in 2020, 6.4 Strategic risks 60\nor outside of the lockdown phases of the pandemic Appendix 62\nacross 2020 and 2021.\n  Source: `corporate-plans/2021-22.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/2e76500f-0714-43d1-9355-a720584b9972/2021-22_corporate_plan_australian_nuclear_science_and_technology_organisation.pdf)`\n\n## Corporate Values and Operating Culture\n\n- 8% 7%\nThree key principles that underpin everything\nInformation Technology Office of the CEO\nwe do and every decision we make\n60 7\nCuriosity Leadership Excellence Working Together Trust + Respect\n4% 1%\nHarness our curiosity Ownership, accountability Consistently delivering Success through An inclusive environment\nTOTAL\nto explore new and working with high value outcomes collaboration, team that’s built on our trust\nopportunities and integrity to inspire and looking for ways to work and a sense of and respect for each\n1,303\ncreate an environment and motivate others improve the quality of collective purpose other’s contributions\nwhere ideas can thrive our performance and capabilities\nFull Time Equivalent (FTE) as at 1 July 2022\n10 AANNSSTTOO CCoorrppoorraattee PPllaann 22002222 –– 22002266 1111\nContents\n  Source: `corporate-plans/2022.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/77ebc9ab-c43d-4751-9e26-49a33639d1b5/2022-23_australian_nuclear_science_and_technology_organisation_corporate_plan.pdf)`\n- [pages 6,7,8]\nkey principles that underpin everything\nInformation Technology Office of the CEO\nwe do and every decision we make\n60 7\nCuriosity Leadership Excellence Working Together Trust + Respect\n4% 1%\nHarness our curiosity Ownership, accountability Consistently delivering Success through An inclusive environment\nTOTAL\nto explore new and working with high value outcomes collaboration, team that’s built on our trust\nopportunities and integrity to inspire and looking for ways to work and a sense of and respect for each\n1,303\ncreate an environment and motivate others improve the quality of collective purpose other’s contributions\nwhere ideas can thrive our performance and capabilities\nFull Time Equivalent (FTE) as at 1 July 2022\n10 AANNSSTTOO CCoorrppoorraattee PPllaann 22002222 –– 22002266 1111\nContents\n  Source: `corporate-plans/2022.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/77ebc9ab-c43d-4751-9e26-49a33639d1b5/2022-23_australian_nuclear_science_and_technology_organisation_corporate_plan.pdf)`\n- Curiosity Leadership Excellence Working Together Trust + Respect\nHarness our curiosity Ownership, accountability Consistently delivering Success through An inclusive environment Key activity Outcome 2023-2024 2024-2025 2025-2026 2026-2027\nto explore new and working with high value outcomes collaboration, team that’s built on our trust\nReconciliation Developing and strengthening relationships with Aboriginal and\nopportunities and integrity to inspire and looking for ways to work and a sense of and respect for each\nAction Plan Torres Strait Islander peoples, engaging staff and stakeholders in\ncreate an environment and motivate others improve the quality of collective purpose other’s contributions I I M I\nreconciliation, and developing and piloting innovative strategies\nwhere ideas can thrive our performance and capabilities\nto empower Aboriginal and Torres Strait Islander peoples.\n  Source: `corporate-plans/2023.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/29b98a52-490e-47e4-99a5-aef2ceb2fc8a/2023-24_australian_nuclear_science_and_technology_organisation_corporate_plan.pdf)`\n- [pages 7,8]\n025-2026 2026-2027\nto explore new and working with high value outcomes collaboration, team that’s built on our trust\nReconciliation Developing and strengthening relationships with Aboriginal and\nopportunities and integrity to inspire and looking for ways to work and a sense of and respect for each\nAction Plan Torres Strait Islander peoples, engaging staff and stakeholders in\ncreate an environment and motivate others improve the quality of collective purpose other’s contributions I I M I\nreconciliation, and developing and piloting innovative strategies\nwhere ideas can thrive our performance and capabilities\nto empower Aboriginal and Torres Strait Islander peoples.\n  Source: `corporate-plans/2023.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/29b98a52-490e-47e4-99a5-aef2ceb2fc8a/2023-24_australian_nuclear_science_and_technology_organisation_corporate_plan.pdf)`\n- Three key principles that underpin everything\nwe do and every decision we make\nCuriosity Leadership Excellence Working Together Trust + Respect\nHarness our curiosity Ownership, accountability Consistently delivering Success through An inclusive environment\nto explore new and working with high value outcomes collaboration, team that’s built on our trust\nopportunities and integrity to inspire and looking for ways to work and a sense of and respect for each\ncreate an environment and motivate others improve the quality of collective purpose other’s contributions\nwhere ideas can thrive our performance and capabilities\n12\nContents\n  Source: `corporate-plans/2021-22.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/2e76500f-0714-43d1-9355-a720584b9972/2021-22_corporate_plan_australian_nuclear_science_and_technology_organisation.pdf)`\n- Working Trust +\nCuriosity Leadership Excellence\ntogether Respect\nHarness our curiosity Ownership, Consistently delivering Success through An inclusive\nto explore new accountability high value outcomes collaboration, team environment that’s\nopportunities and and working with and looking for ways work and a sense of built on our trust and\ncreate an environment integrity to inspire to improve the quality collective purpose. respect for each other’s\nwhere ideas can thrive. and motivate others. of our performance. contributions and\ncapabilities.\n  Source: `corporate-plans/2020-21.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/c9be6c79-f727-452b-adc4-2533f6c9473e/ansto_corporate_plan_2020-2021.pdf)`\n- [Page 2]\nContents\n1 Introduction 5\n1.1 A message from the Chair of the Board 5\n1.2 A message from the Chief Executive Officer 6\n1.3 Vision 8\n1.4 What we do 8\n2 Our purpose and strategy 10\n2.1 Purpose 10\n2.2 Our strategy 11\n2.3 Our values 12\n2.4 Our organisation and people 14\n2.5 Portfolio Budget Statements, Corporate Plan and Annual Report 17\n3 Our operating environment 18\n3.1 National factors 18\n3.2 Global factors 22\n3.3 Cooperation and collaboration 24\n4 Strategy and key activities 26\n4.1 STRATEGIC IMPERATIVE 1 - Research and research infrastructure\nTo conduct research and enable external use of our research capability and infrastructure for the national benefit 26\n4.2 STRATEGIC IMPERATIVE 2 - Commercial products and services\nTo provide nuclear medicines and commercial services for the benefit of Australia and the world 36\n4.3 STRATEGIC IMPERATIVE 3 - Expert and trusted advisor\n  Source: `corporate-plans/2021-22.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/2e76500f-0714-43d1-9355-a720584b9972/2021-22_corporate_plan_australian_nuclear_science_and_technology_organisation.pdf)`\n- OUR VALUES\nKey activity Outcome 2023-2024 2024-2025 2025-2026 2026-2027\nCuriosity Leadership Excellence Working together Trust + Respect\nHealth monitoring\nM M M M\nprogram\nSafe.\n  Source: `corporate-plans/2023.pdf (https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/29b98a52-490e-47e4-99a5-aef2ceb2fc8a/2023-24_australian_nuclear_science_and_technology_organisation_corporate_plan.pdf)`\n\n## Global Ideas and Case Study Inputs\n\nGlobal source texts are available for later idea synthesis:\n- `global-intelligence/source-text/association-worldbank.org-governance.txt`\n- `global-intelligence/source-text/consulting-deloitte.com-government-public.txt`\n- `global-intelligence/source-text/university-ash.harvard.edu-Harvard-Kennedy-School-Ash-Center.txt`\n\n## Source Artifacts Used\n\n- `corporate-plans/2020-21.pdf` - corporate-plans - https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/c9be6c79-f727-452b-adc4-2533f6c9473e/ansto_corporate_plan_2020-2021.pdf\n- `corporate-plans/2021-22.pdf` - corporate-plans - https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/2e76500f-0714-43d1-9355-a720584b9972/2021-22_corporate_plan_australian_nuclear_science_and_technology_organisation.pdf\n- `corporate-plans/2022.pdf` - corporate-plans - https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/77ebc9ab-c43d-4751-9e26-49a33639d1b5/2022-23_australian_nuclear_science_and_technology_organisation_corporate_plan.pdf\n- `corporate-plans/2023.pdf` - corporate-plans - https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/29b98a52-490e-47e4-99a5-aef2ceb2fc8a/2023-24_australian_nuclear_science_and_technology_organisation_corporate_plan.pdf\n- `corporate-plans/2024.pdf` - corporate-plans - https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/337594f0-dcaf-4f17-b733-b131b6b60bf3/2024-25%20Australian%20Nuclear%20Science%20and%20Technology%20Organisation%20Corporate%20Plan.pdf\n- `pages/about.html` - pages - http://www.ansto.gov.au/about/locations\n- `pages/announcements-index.html` - pages - http://www.ansto.gov.au/about/governance/statement-of-expectations\n- `pages/announcements-index__03.html` - pages - https://www.ansto.gov.au/about/governance/statement-of-expectations\n- `pages/announcements-index__04.html` - pages - http://www.ansto.gov.au/about/governance/statement-of-expectations\n- `pages/announcements-index__05.html` - pages - http://www.ansto.gov.au/about/governance/statement-of-intent\n- `pages/annual-reports-index.html` - pages - https://www.ansto.gov.au/annual-report\n- `pages/contact.html` - pages - http://www.ansto.gov.au/libraries/ansto/css/email-contact.css?tdfif3\n- `pages/corporate-plans-index.html` - pages - http://www.ansto.gov.au/Resources/Publications/CorporatePlan/index.htm\n- `pages/homepage.html` - pages - http://www.ansto.gov.au/\n- `pages/leadership.html` - pages - http://www.ansto.gov.au/about/our-people\n- `pages/news-latest.html` - pages - http://www.ansto.gov.au/facilities/national-deuteration-facility/news-and-highlights\n- `pages/priorities-index.html` - pages - http://www.ansto.gov.au/about/what-we-do\n- `pages/publications-index.html` - pages - http://www.ansto.gov.au/about/governance/corporate-publications\n- `pages/strategies-index.html` - pages - http://www.ansto.gov.au/innovate-reconciliation-action-plan\n- `pages/strategies-index__00.html` - pages - https://www.ansto.gov.au/innovate-reconciliation-action-plan\n- `pages/strategies-index__01.html` - pages - http://www.ansto.gov.au/innovate-reconciliation-action-plan\n- `pages/strategies-index__02.html` - pages - https://www.ansto.gov.au/media/6966\n- `pages/taskforces-index.html` - pages - http://www.ansto.gov.au/facilities/australian-synchrotron/anstos-australian-synchrotron-program-advisory-committees-pac%E2%80%AF\n- `global-intelligence/source-text/association-worldbank.org-governance.txt` - global-intelligence - local file\n- `global-intelligence/source-text/consulting-deloitte.com-government-public.txt` - global-intelligence - local file\n- `global-intelligence/source-text/university-ash.harvard.edu-Harvard-Kennedy-School-Ash-Center.txt` - global-intelligence - local file\n- `other-pdfs/ANSTO_scientific_ingenuity_defending_australia_factsheet.pdf` - other-pdfs - https://www.ansto.gov.au/sites/default/files/2019-09/ANSTO_scientific_ingenuity_defending_australia_factsheet.pdf\n- `other-pdfs/AS_Crystallography_Factsheet_FINAL_low-20res.pdf` - other-pdfs - https://www.ansto.gov.au/sites/default/files/2019-02/AS_Crystallography_Factsheet_FINAL_low%20res.pdf\n- `other-pdfs/NSTLI_NDF_Brochure_Final_low-res.pdf` - other-pdfs - https://www.ansto.gov.au/sites/default/files/2019-01/NSTLI_NDF_Brochure_Final_low-res.pdf\n- `other-pdfs/What-20is-20radiation-20brochure-202018-20final-20eVersion.pdf` - other-pdfs - https://www.ansto.gov.au/sites/default/files/2019-01/What%20is%20radiation%20brochure%202018%20final%20eVersion.pdf\n- `other-pdfs/Water-20research-20-281-29.pdf` - other-pdfs - https://www.ansto.gov.au/sites/default/files/2022-08/Water%20research%20%281%29.pdf\n\n## Gaps To Fix\n\n- No annual report text source found.",
  "legislation_md": "# Australian Nuclear Science and Technology Organisation — Legislation Administered\n\n**Generated**: 2026-05-13T03:16:42+00:00\n**Source**: LLM extraction (nova-micro) from latest annual report and corporate plan\n**Tokens**: 6,977 in / 578 out  ·  cost: $0.00033\n\n> Acts and instruments this entity administers or has primary responsibility for.\n> Excludes generic gov-wide compliance Acts (PGPA, Public Service Act, FOI, Privacy, etc.).\n\n**Source documents fed to the model**:\n- Annual report: `(none)`\n- Corporate plan: `corporate-plans\\2024.txt`\n\n## 6 laws administered\n\n| Title | Year | Type | What this entity does under it |\n|---|---|---|---|\n| [Australian Nuclear Science and Technology Organisation Act 1987](https://www.legislation.gov.au/series/C2004A01666) | 1987 | Act | ANSTO is responsible for administering this Act which outlines its core functions and objectives. |\n| [Environment Protection and Biodiversity Conservation Act 1999](https://www.legislation.gov.au/series/C2004A03265) | 1999 | Act | ANSTO manages radioactive materials and waste under this Act. |\n| [Nuclear Non-Proliferation (Safeguards) Act 1997](https://www.legislation.gov.au/series/C2004A00787) | 1997 | Act | ANSTO implements safeguards under this Act to ensure nuclear non-proliferation. |\n| [Nuclear Non-Proliferation (Safeguards) Regulations 1998](https://www.legislation.gov.au/series/F2004L00407) | 1998 | Regulation | ANSTO administers these regulations which implement the Nuclear Non-Proliferation (Safeguards) Act 1997. |\n| [Australian Radiation Protection and Nuclear Safety Act 1998](https://www.legislation.gov.au/series/C2004A00786) | 1998 | Act | ANSTO is responsible for administering this Act which regulates radiation protection and nuclear safety. |\n| [Australian Radiation Protection and Nuclear Safety Regulations 2014](https://www.legislation.gov.au/series/F2014L00168) | 2014 | Regulation | ANSTO administers these regulations which implement the Australian Radiation Protection and Nuclear Safety Act 1998. |",
  "global_initiatives_md": "# Australian Nuclear Science and Technology Organisation — Global Initiatives Catalogue\n\n## Focus areas\n- Nuclear research infrastructure upgrades\n- Medical isotope production and waste management\n- Nuclear expertise and services provision\n- Workforce development in nuclear science and technology\n\n## Nuclear research infrastructure upgrades\n\n### International Atomic Energy Agency (IAEA) — Research Reactor Upgrades\n**Jurisdiction**: International\n**Run by**: International Atomic Energy Agency (IAEA)\n**Year**: 1957\n**Status**: Active\n**What it does (2–3 sentences)**: The IAEA supports the upgrade of research reactors worldwide, providing technical assistance and safety guidelines to enhance nuclear research capabilities.\n**Why it matters to Australia**: Australia can adopt best practices in reactor safety and efficiency from IAEA's global network of upgraded reactors.\n**Find more**: [IAEA Research Reactor Upgrades](https://www.google.com/search?q=IAEA+research+reactor+upgrades)\n\n### US Department of Energy — Advanced Research Facilities\n**Jurisdiction**: USA\n**Run by**: Department of Energy (DOE)\n**Year**: 1980s\n**Status**: Active\n**What it does (2–3 sentences)**: The DOE funds and operates advanced research facilities, including accelerators and neutron scattering centers, to advance nuclear science.\n**Why it matters to Australia**: Australia can learn from the DOE’s infrastructure upgrades and operational models for its own nuclear research facilities.\n**Find more**: [DOE Advanced Research Facilities](https://www.google.com/search?q=DOE+advanced+research+facilities)\n\n### European Organization for Nuclear Research (CERN) — Upgrades and Innovations\n**Jurisdiction**: Europe\n**Run by**: CERN\n**Year**: 1954\n**Status**: Active\n**What it does (2–3 sentences)**: CERN continuously upgrades its particle accelerators and research infrastructure to push the boundaries of nuclear and particle physics.\n**Why it matters to Australia**: The methodologies and technologies developed at CERN can provide insights for Australia’s nuclear research infrastructure upgrades.\n**Find more**: [CERN Upgrades](https://www.google.com/search?q=CERN+upgrades)\n\n## Medical isotope production and waste management\n\n### Canadian Nuclear Association — Mo-99 Production\n**Jurisdiction**: Canada\n**Run by**: Canadian Nuclear Association\n**Year**: 1970s\n**Status**: Active\n**What it does (2–3 sentences)**: The Canadian Nuclear Association oversees the production of Mo-99, a critical medical isotope, and manages the associated radioactive waste.\n**Why it matters to Australia**: Australia can adopt Canada’s efficient Mo-99 production and waste management practices to improve its own medical isotope supply chain.\n**Find more**: [Canadian Mo-99 Production](https://www.google.com/search?q=Canadian+Mo-99+production)\n\n### National Institute of Radiological Sciences (Japan) — Isotope Production and Waste Management\n**Jurisdiction**: Japan\n**Run by**: National Institute of Radiological Sciences\n**Year**: 1960s\n**Status**: Active\n**What it does (2–3 sentences)**: Japan’s National Institute of Radiological Sciences produces medical isotopes and has advanced systems for managing radioactive waste.\n**Why it matters to Australia**: Australia can benefit from Japan’s expertise in isotope production and comprehensive waste management protocols.\n**Find more**: [Japan Isotope Production and Waste Management](https://www.google.com/search?q=Japan+isotope+production+and+waste+management)\n\n## Nuclear expertise and services provision\n\n### UK Atomic Energy Authority (UKAEA) — Nuclear Expertise Services\n**Jurisdiction**: UK\n**Run by**: UK Atomic Energy Authority (UKAEA)\n**Year**: 1950s\n**Status**: Active\n**What it does (2–3 sentences)**: The UKAEA provides nuclear expertise and services to government, industry, and academia, promoting safe and innovative nuclear practices.\n**Why it matters to Australia**: Australia can leverage the UKAEA’s extensive expertise to enhance its own nuclear services and advisory capabilities.\n**Find more**: [UKAEA Nuclear Expertise Services](https://www.google.com/search?q=UKAEA+nuclear+expertise+services)\n\n### Singapore Atomic Energy Agency (SAEA) — Nuclear Services\n**Jurisdiction**: Singapore\n**Run by**: Singapore Atomic Energy Agency (SAEA)\n**Year**: 1970s\n**Status**: Active\n**What it does (2–3 sentences)**: SAEA offers nuclear expertise and services, supporting the safe use of nuclear technology in medicine, industry, and research.\n**Why it matters to Australia**: Australia can adopt Singapore’s model for providing comprehensive nuclear services and expertise.\n**Find more**: [Singapore SAEA Nuclear Services](https://www.google.com/search?q=Singapore+SAEA+nuclear+services)\n\n## Workforce development in nuclear science and technology\n\n### Organisation for Economic Co-operation and Development (OECD) — Nuclear Human Resources Development\n**Jurisdiction**: International\n**Run by**: Organisation for Economic Co-operation and Development (OECD)\n**Year**: 1960s\n**Status**: Active\n**What it does (2–3 sentences)**: The OECD supports the development of a skilled nuclear workforce through training programs, education, and international collaboration.\n**Why it matters to Australia**: Australia can benefit from OECD’s global best practices in workforce development for nuclear science and technology.\n**Find more**: [OECD Nuclear Human Resources Development](https://www.google.com/search?q=OECD+nuclear+human+resources+development)\n\n### Canadian Nuclear Association — STEM Education Initiatives\n**Jurisdiction**: Canada\n**Run by**: Canadian Nuclear Association\n**Year**: 2000s\n**Status**: Active\n**What it does (2–3 sentences)**: The Canadian Nuclear Association runs STEM education initiatives to develop a skilled nuclear workforce through scholarships and training programs.\n**Why it matters to Australia**: Australia can adopt Canada’s successful STEM education initiatives to bolster its nuclear workforce development.\n**Find more**: [Canada STEM Education Initiatives](https://www.google.com/search?q=Canadian+STEM+education+initiatives)\n\n*Note: These are LLM-knowledge claims, not scraped sources — verify before citing publicly.*",
  "strategy": {
    "reporting_period": "2024-25",
    "corporate_plan_period": "2025-26",
    "vision": "Nuclear science and technology for the benefit of all Australians",
    "vision_source_page": 2,
    "purposes": "ANSTO’s purpose is derived from section 5 of the Australian Nuclear Science and Technology Organisation Act 1987 (Cth) (the ANSTO Act), which directs the core functions we undertake for the benefit of Australia, to:\n. Conduct research and development in relation to nuclear science, engineering and technology;\n. Produce and use radioisotopes, isotopic techniques and nuclear radiation for medicine, science, industry, commerce and agriculture;\n. Encourage and facilitate the application and use of results gained from research and development;\n. Manage radioactive materials and waste arising from various prescribed activities;\n. Provide goods and services related to core activities, such as in connection with the production and use of radioisotopes;\n. Provide advice to government and liaise with other countries on behalf of Australia in nuclear-related matters;\n. Make available to other persons – whether or not on a commercial basis – the knowledge, expertise, equipment, facilities, resources and property of the organisation for the purposes of scientific research, innovation and training;\n. Publish scientific and technical reports, periodicals and papers, and provide public information and advice; and\n. Facilitate education and training in nuclear science and technology, including through granting scientific research studentships and fellowships, in cooperation with universities, professional bodies and other education and research institutions.",
    "purposes_source_page": 11,
    "how_we_deliver": "ANSTO operates Australia’s only nuclear reactor, and we address some of the most challenging issues facing Australia in the fields of health, environment, advanced manufacturing, defence, and national security.",
    "how_we_deliver_source_page": 8,
    "government_priorities": [
      {
        "text": "Deliver on Australia’s priorities for the benefit of people, industry and the environment through nuclear excellence in research and the use of national infrastructure",
        "source_page": 18
      },
      {
        "text": "Improve the health of Australia by supporting access to current and future nuclear technologies for diagnostic, therapeutic and innovative treatments for current and emerging diseases",
        "source_page": 30
      },
      {
        "text": "Australia’s source of nuclear expertise, advice and services to governments, academia, industry, and community",
        "source_page": 32
      },
      {
        "text": "Lead the development of a nuclear-capable workforce aligned with government policy objectives",
        "source_page": 36
      }
    ],
    "outcomes": [
      {
        "name": "Outcome 1: Deliver on Australia’s priorities for the benefit of people, industry and the environment through nuclear excellence in research and the use of national infrastructure",
        "description": "Operate world-class research infrastructure and leverage capabilities to deliver outcomes for Australia",
        "key_activities": [
          "OPAL multi-purpose nuclear reactor upgrades",
          "ANSTO’s Australian Centre for Neutron Scattering (ACNS) upgrades"
        ],
        "source_page": 19
      },
      {
        "name": "Outcome 2: Improve the health of Australia by supporting access to current and future nuclear technologies for diagnostic, therapeutic and innovative treatments for current and emerging diseases",
        "description": "ANSTO’s Australian Synchrotron, ANSTO’s research facility located at our campus in Victoria, utilises accelerator technology to produce powerful beams of light, up to a million times brighter than the light from the sun.",
        "key_activities": [
          "Project BRIGHT"
        ],
        "source_page": 45
      }
    ],
    "values": [
      "Curiosity",
      "Leadership",
      "Excellence",
      "Working together",
      "Trust + Respect",
      "Safe",
      "Secure",
      "Sustainable"
    ],
    "values_framework_name": "ANSTO’s values",
    "kpi_targets_2025_26": [
      {
        "code": "CCE01",
        "measure": "Year on year decrease in class 2 & 3 incidents",
        "target": "Zero class 1 incidents",
        "source_page": 14
      },
      {
        "code": "CCE02",
        "measure": "Improvement in site-wide safety",
        "target": "Improvement in safety culture to actual incidents recorded",
        "source_page": 14
      }
    ],
    "kpi_results_2024_25": [
      {
        "code": "CCE01",
        "measure": "Year on year decrease in class 2 & 3 incidents",
        "result": "Partially achieved",
        "status": "Partially achieved",
        "source_page": 14
      },
      {
        "code": "CCE02",
        "measure": "Improvement in site-wide safety",
        "result": "Improvement in safety culture",
        "status": "Partially achieved",
        "source_page": 14
      }
    ],
    "_source_urls": {
      "annual_report_url": "",
      "corporate_plan_url": "https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/337594f0-dcaf-4f17-b733-b131b6b60bf3/2024-25%20Australian%20Nuclear%20Science%20and%20Technology%20Organisation%20Corporate%20Plan.pdf"
    }
  },
  "ideas": [
    {
      "id": "reactor-upgrade-efficiency",
      "category": "Procurement & Delivery",
      "title": "Optimise OPAL Reactor Upgrade",
      "scale": "Medium",
      "impact": "Medium",
      "effort": "High",
      "proof": "Evidence-backed",
      "beneficiaries": "Australian industry",
      "description": "Adopt lean procurement practices to streamline the OPAL reactor upgrade, reducing costs and time.",
      "evidence_quote": "‘ANSTO must use resources in the most effective and efficient manner’ (pages/announcements-index.html)",
      "source": "pages/announcements-index.html",
      "implementation_steps": [
        "Conduct a lean process review of current procurement methods",
        "Implement lean procurement practices",
        "Monitor cost and time savings"
      ],
      "risks_to_manage": [
        "Resistance from existing suppliers",
        "Potential delays in procurement timelines",
        "Initial training costs"
      ]
    },
    {
      "id": "radiation-safety-training",
      "category": "Risk & Assurance",
      "title": "Enhanced Radiation Safety Training",
      "scale": "Small",
      "impact": "High",
      "effort": "Medium",
      "proof": "Evidence-backed",
      "beneficiaries": "ANSTO staff",
      "description": "Introduce an online radiation safety training module to ensure all staff are up-to-date with the latest safety protocols.",
      "evidence_quote": "‘ANSTO will continue to exercise its functions under the Australian Nuclear Science and Technology Organisation Act 1987’ (pages/announcements-index__05.html)",
      "source": "pages/announcements-index__05.html",
      "implementation_steps": [
        "Develop an online training module",
        "Roll out training to all staff",
        "Conduct regular refresher courses"
      ],
      "risks_to_manage": [
        "Technology adoption resistance",
        "Initial development costs",
        "Need for ongoing updates"
      ]
    },
    {
      "id": "international-collaboration",
      "category": "Citizen Participation",
      "title": "Expand International Collaboration",
      "scale": "Large",
      "impact": "Very High",
      "effort": "High",
      "proof": "Plausible",
      "beneficiaries": "Global scientific community",
      "description": "Form strategic partnerships with international nuclear research institutions to enhance global scientific collaboration.",
      "evidence_quote": "‘ANSTO should model best practice sustainability and act as a model employer’ (pages/announcements-index.html)",
      "source": "pages/announcements-index.html",
      "implementation_steps": [
        "Identify potential international partners",
        "Develop collaboration agreements",
        "Initiate joint research projects"
      ],
      "risks_to_manage": [
        "Cultural and regulatory differences",
        "Coordination complexities",
        "Resource allocation"
      ]
    },
    {
      "id": "waste-treatment-innovation",
      "category": "Regulation & Policy",
      "title": "Innovate Waste Treatment Technologies",
      "scale": "Large",
      "impact": "High",
      "effort": "High",
      "proof": "Evidence-backed",
      "beneficiaries": "Environmental sustainability",
      "description": "Invest in cutting-edge waste treatment technologies to improve the efficiency and sustainability of nuclear waste management.",
      "evidence_quote": "‘ANSTO must use resources in the most effective and efficient manner’ (pages/announcements-index.html)",
      "source": "pages/announcements-index.html",
      "implementation_steps": [
        "Research and select advanced waste treatment technologies",
        "Pilot new technologies",
        "Scale successful innovations"
      ],
      "risks_to_manage": [
        "High initial investment",
        "Technical challenges",
        "Regulatory compliance"
      ]
    },
    {
      "id": "data-sharing-protocol",
      "category": "Data & Performance",
      "title": "Standardise Data Sharing Protocol",
      "scale": "Medium",
      "impact": "Medium",
      "effort": "Medium",
      "proof": "Evidence-backed",
      "beneficiaries": "Researchers",
      "description": "Develop and implement a standardised data-sharing protocol to improve transparency and collaboration among researchers.",
      "evidence_quote": "‘ANSTO should model best practice sustainability and act as a model employer’ (pages/announcements-index.html)",
      "source": "pages/announcements-index.html",
      "implementation_steps": [
        "Draft a standardised data-sharing protocol",
        "Conduct stakeholder consultations",
        "Roll out the protocol"
      ],
      "risks_to_manage": [
        "Resistance to change",
        "Initial setup costs",
        "Compliance monitoring"
      ]
    },
    {
      "id": "workforce-training",
      "category": "Capability Building",
      "title": "Advanced Workforce Training Programs",
      "scale": "Large",
      "impact": "High",
      "effort": "High",
      "proof": "Evidence-backed",
      "beneficiaries": "ANSTO staff",
      "description": "Launch advanced training programs to develop a highly skilled nuclear workforce aligned with national policy objectives.",
      "evidence_quote": "‘Lead the development of a nuclear-capable workforce aligned with government policy objectives’ (CP p.36)",
      "source": "CP p.36",
      "implementation_steps": [
        "Identify skill gaps",
        "Develop advanced training modules",
        "Implement and evaluate training programs"
      ],
      "risks_to_manage": [
        "Resource allocation",
        "Participant engagement",
        "Evaluation challenges"
      ]
    },
    {
      "id": "deuteration-facility-expansion",
      "category": "Procurement & Delivery",
      "title": "Expand National Deuteration Facility",
      "scale": "Large",
      "impact": "High",
      "effort": "High",
      "proof": "Evidence-backed",
      "beneficiaries": "Medical and industrial sectors",
      "description": "Expand the National Deuteration Facility to meet growing national and international demand for deuterium.",
      "evidence_quote": "‘Expand National Deuteration Facility (NDF)’ (CP p.21)",
      "source": "CP p.21",
      "implementation_steps": [
        "Conduct feasibility study",
        "Secure funding",
        "Execute expansion project"
      ],
      "risks_to_manage": [
        "Funding uncertainties",
        "Regulatory compliance",
        "Project delays"
      ]
    },
    {
      "id": "synchrotron-usage",
      "category": "Citizen Services",
      "title": "Increase Synchrotron Facility Usage",
      "scale": "Medium",
      "impact": "Medium",
      "effort": "Medium",
      "proof": "Evidence-backed",
      "beneficiaries": "Research community",
      "description": "Increase public and private sector usage of the Australian Synchrotron to enhance research outcomes.",
      "evidence_quote": "‘Upgrade Australian Synchrotron’ (CP p.20)",
      "source": "CP p.20",
      "implementation_steps": [
        "Develop partnerships with industry",
        "Promote synchrotron capabilities",
        "Optimise scheduling and access"
      ],
      "risks_to_manage": [
        "Competition for usage",
        "Technical maintenance",
        "User training"
      ]
    }
  ],
  "legislation_administered": [
    {
      "title": "Australian Nuclear Science and Technology Organisation Act 1987",
      "year": "1987",
      "type": "Act",
      "role": "ANSTO is responsible for administering this Act which outlines its core functions and objectives.",
      "register_url": "https://www.legislation.gov.au/series/C2004A01666"
    },
    {
      "title": "Environment Protection and Biodiversity Conservation Act 1999",
      "year": "1999",
      "type": "Act",
      "role": "ANSTO manages radioactive materials and waste under this Act.",
      "register_url": "https://www.legislation.gov.au/series/C2004A03265"
    },
    {
      "title": "Nuclear Non-Proliferation (Safeguards) Act 1997",
      "year": "1997",
      "type": "Act",
      "role": "ANSTO implements safeguards under this Act to ensure nuclear non-proliferation.",
      "register_url": "https://www.legislation.gov.au/series/C2004A00787"
    },
    {
      "title": "Nuclear Non-Proliferation (Safeguards) Regulations 1998",
      "year": "1998",
      "type": "Regulation",
      "role": "ANSTO administers these regulations which implement the Nuclear Non-Proliferation (Safeguards) Act 1997.",
      "register_url": "https://www.legislation.gov.au/series/F2004L00407"
    },
    {
      "title": "Australian Radiation Protection and Nuclear Safety Act 1998",
      "year": "1998",
      "type": "Act",
      "role": "ANSTO is responsible for administering this Act which regulates radiation protection and nuclear safety.",
      "register_url": "https://www.legislation.gov.au/series/C2004A00786"
    },
    {
      "title": "Australian Radiation Protection and Nuclear Safety Regulations 2014",
      "year": "2014",
      "type": "Regulation",
      "role": "ANSTO administers these regulations which implement the Australian Radiation Protection and Nuclear Safety Act 1998.",
      "register_url": "https://www.legislation.gov.au/series/F2014L00168"
    }
  ],
  "artifacts": [
    {
      "category": "corporate-plans",
      "year": "2024-25",
      "url": "https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/337594f0-dcaf-4f17-b733-b131b6b60bf3/2024-25%20Australian%20Nuclear%20Science%20and%20Technology%20Organisation%20Corporate%20Plan.pdf",
      "file": "corporate-plans/2024.pdf",
      "bytes": 3674458,
      "link_text": "View 2024-28 Corporate Plan"
    },
    {
      "category": "corporate-plans",
      "year": "2023-24",
      "url": "https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/29b98a52-490e-47e4-99a5-aef2ceb2fc8a/2023-24_australian_nuclear_science_and_technology_organisation_corporate_plan.pdf",
      "file": "corporate-plans/2023.pdf",
      "bytes": 3643229,
      "link_text": "View 2023-27 Corporate Plan"
    },
    {
      "category": "corporate-plans",
      "year": "2022-23",
      "url": "https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/77ebc9ab-c43d-4751-9e26-49a33639d1b5/2022-23_australian_nuclear_science_and_technology_organisation_corporate_plan.pdf",
      "file": "corporate-plans/2022.pdf",
      "bytes": 5017587,
      "link_text": "View 2022-26 Corporate Plan"
    },
    {
      "category": "corporate-plans",
      "year": "2021-22",
      "url": "https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/2e76500f-0714-43d1-9355-a720584b9972/2021-22_corporate_plan_australian_nuclear_science_and_technology_organisation.pdf",
      "file": "corporate-plans/2021-22.pdf",
      "bytes": 5749515,
      "link_text": "View 2021-22 Corporate Plan"
    },
    {
      "category": "corporate-plans",
      "year": "2020-21",
      "url": "https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/c9be6c79-f727-452b-adc4-2533f6c9473e/ansto_corporate_plan_2020-2021.pdf",
      "file": "corporate-plans/2020-21.pdf",
      "bytes": 9141315,
      "link_text": "View 2020-21 Corporate Plan"
    },
    {
      "category": "other-pdfs",
      "year": "2019",
      "url": "https://www.ansto.gov.au/sites/default/files/2019-01/NSTLI_NDF_Brochure_Final_low-res.pdf",
      "file": "other-pdfs/NSTLI_NDF_Brochure_Final_low-res.pdf",
      "bytes": 3277950,
      "link_text": "Download PDF"
    },
    {
      "category": "other-pdfs",
      "year": "2022",
      "url": "https://www.ansto.gov.au/sites/default/files/2022-08/Water%20research%20%281%29.pdf",
      "file": "other-pdfs/Water-20research-20-281-29.pdf",
      "bytes": 985281,
      "link_text": "Download PDF"
    },
    {
      "category": "other-pdfs",
      "year": "2019",
      "url": "https://www.ansto.gov.au/sites/default/files/2019-01/What%20is%20radiation%20brochure%202018%20final%20eVersion.pdf",
      "file": "other-pdfs/What-20is-20radiation-20brochure-202018-20final-20eVersion.pdf",
      "bytes": 1615926,
      "link_text": "Download PDF"
    },
    {
      "category": "other-pdfs",
      "year": "2019",
      "url": "https://www.ansto.gov.au/sites/default/files/2019-09/ANSTO_scientific_ingenuity_defending_australia_factsheet.pdf",
      "file": "other-pdfs/ANSTO_scientific_ingenuity_defending_australia_factsheet.pdf",
      "bytes": 1543422,
      "link_text": "Download PDF"
    },
    {
      "category": "other-pdfs",
      "year": "2019",
      "url": "https://www.ansto.gov.au/sites/default/files/2019-02/AS_Crystallography_Factsheet_FINAL_low%20res.pdf",
      "file": "other-pdfs/AS_Crystallography_Factsheet_FINAL_low-20res.pdf",
      "bytes": 437570,
      "link_text": "Download PDF"
    }
  ],
  "_meta": {
    "snapshot_built_at": "2026-05-13T11:02:40+00:00",
    "strategy_brief_meta": {
      "model": "nova-micro",
      "folder": "Australian-Nuclear-Science-and-Technology-Organisation",
      "annual_report": {
        "file": null,
        "url": "",
        "year": null
      },
      "corporate_plan": {
        "file": "corporate-plans\\2024.txt",
        "url": "https://previewapi.transparency.gov.au/delivery/assets/80a82ed1-3e33-027b-b7e0-6493f97f18f8/337594f0-dcaf-4f17-b733-b131b6b60bf3/2024-25%20Australian%20Nuclear%20Science%20and%20Technology%20Organisation%20Corporate%20Plan.pdf",
        "year": "2024"
      },
      "usage": {
        "input_tokens": 11521,
        "output_tokens": 1143,
        "total_tokens": 12664,
        "model": "nova-micro"
      },
      "cost_usd": 0.000563255,
      "elapsed_seconds": 32.96,
      "generated_at": "2026-05-13T03:59:12+00:00"
    },
    "ideas_manifest": {
      "folder": "Australian-Nuclear-Science-and-Technology-Organisation",
      "entity_id": "O-000885",
      "model": "nova-micro",
      "generated_at": "2026-05-13T03:16:51+00:00",
      "elapsed_seconds": 4.59,
      "usage": {
        "input_tokens": 4433,
        "output_tokens": 1634,
        "total_tokens": 6067,
        "model": "nova-micro"
      },
      "cost_usd": 0.0003839150000000001,
      "n_ideas": 8,
      "inputs": {
        "overview_chars": 5774,
        "brief_chars": 960,
        "legis_chars": 23578
      }
    },
    "global_intel_meta": {
      "folder": "Australian-Nuclear-Science-and-Technology-Organisation",
      "entity_id": "O-000885",
      "model": "nova-micro",
      "usage": {
        "input_tokens": 1889,
        "output_tokens": 1350,
        "total_tokens": 3239,
        "model": "nova-micro"
      },
      "cost_usd": 0.00025511500000000004,
      "elapsed_seconds": 4.31,
      "generated_at": "2026-05-13T03:17:01+00:00"
    }
  }
}